• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention is directed to a process for the displacement of the acetoxy group of a cephalosporanic acid by a sulfur nucleophile, in an organic solvent and under essentially anhydrous conditions.
    公开号:SU919596A3
    申请号:SU782586703
    申请日:1978-03-06
    公开日:1982-04-07
    发明作者:Делосс Хатфилд Лоувелл
    申请人:Эли Лилли Энд Компани (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to a process for the preparation of pefaposporin compounds of the general formula AND Hg-f-g, where P is hydrogen or a methoxy group; R is a fsrmammagogroup, the form group Q mules 1 c-CH-C-MH. where is hydrogen, phenyl, phenox-, thienyl, tetrazol-1-ny 1 Shano-p chlorophenylthio, phenethylthio, or rH oxycarbonimide; to RI. - a group of the general formula O% -HN-C-1GN-o lr where Rg is phenyl ;. RS -, urendo, formi (iloxy nli tert-butoxycarbonylradn; or RS Fbnip or oxyphenip; or Rg - 4-ethyl-2,3-dioxopiperazionpkarbonylaminadnkal; or RZ - group of the general formula / -H with n-sn- (sn2) s -If where R7 is hydrogen or methyl; or. is a group of the formula yn -R where Pb is hydrogen or sissigroup; Rg is t-butoxycarbonyl or dimethylureido-carbonyl; or Rj is t-butoxycarbonylamino or 3-chloropropionamido radical, RJ is tetrazoic-5 -yl, unsubstituted or substituted by methyl, benzyl, sulfenyloxy- or carboxymethyl radical, oxadiazol-5-yl, unsubstituted or substituted meth 1,4-thiadiazol-2ip, unsubstituted and pi 5-substituted by methyl, phenyl, 1V-methylacetamide or methyptoradicapic, triazop-5-yl, unsubstituted or substituted with benzyl or benzipoxycarbonylaminomethyl, 4-phenyl-2-thiazolyl, 2-pyrimidinyl, amidino, benzoyl, phenyl, methyl, 2-oxazolyl; 2-benzthiazolyl or 4,5-dihydro-6-hydroxy-4-metip-5-oxo-1, 2,4-triazinyl, provided that f-methoxy group, when Rc-phenyl or tetrazol-X-yl, possessing biologically active properties and are used in medicine. It is known to obtain cephalosporin compounds containing in position 33 a substituted thiomethyl substituent by the interaction of the corresponding 3-alkanoyloxymethyl cephalosporin with the corresponding thiol. Closest to the present invention is a method for preparing cephalosporin compounds, mono-mixed at position 7 and containing at position 35-substituted thiomethyl. substitute by reacting respectively 7-mono-mixed 3-lower alkanoyl oxime of l-3-cephem-4-carboxylic acid or its salt with the corresponding thiol or, in the preparation of 3-aydinothiomethyl derivatives of cephalosporin with thiourea, in an aqueous medium or in a mixture of water and a water-miscible organic solvent at room temperature or under heating, for example IS-TOC, and pH 5.0-8.0, preferably 6-7 i. The disadvantage of this method is the technological complexity of the process due to the fact that cephalosporanic acids have low solubility in aqueous systems and the reaction proceeds very slowly, and in order to speed up the reaction, the initial acid should be converted to salt, and the resulting product should then be converted from salt to target acid The chain of the invention is a simplification of the process technology. This process is achieved by the method of obtaining compounds of the general formula I, which is implied in the fact that the compound of the general formula BI. Bgff - - SNGHWOKI SOON where K and RI are the indicated values; 1, o - C, - 5-alkyl or cyclobutyl, is reacted with a compound of the formula BZ-3N. where Rj is the indicated values, except for the amino radical, or, in the case of Kb, an amidino radical, with thiourea, when heated in an organic solvent with a water content of less than 5 wt.% in the reaction mixture. The process is conducted in a wide range of temperatures. Thus, temperatures of 50-140 ° C can be used, but the best results are obtained at O-120s. The reaction can be carried out at elevated pressure, but there are no advantages. Therefore, the ferric pressure is applied. Suitable organic solvents are members of the following classes of solvents: hydrocarbons, such as aliphatic and aromatic, alcohols, amides, esters, ketones, carboxylic acids, carboxylic esters, halogenated hydrocarbons, nitro compounds, nitriles or thioesters. Since some of the reactants are liquids, such a reactant can also serve as a solvent. The solvent must be inert, i.e. it should not react with any of the reagents. Particularly predpochtitetshnymi solvents are atsetonitrip, 1,2-dichloroethane, methylene chloride, propionitrile, nitromethane, nitroethane, acetic acid, isopropyl acetate, butyl acetate, methyl isobutyl ketone, fluorobenzene, thiophene, methyl ethyl ketone, 1,1,2-trihporetan, chloroform, benzene, chetyrehh carbon monoxide, isopropanol, nitrobenzene, propylene carbonate ethylene carbonate, 2-nitropropane and butyl formate. Regardless of the type of solvent, it is necessary to carry out the proposed method almost in an anhydrous medium. The reaction mixture should contain less than 5% water, preferably less than 1%. It is even better that the amount of water is less than 0.5%. If technical reagents and solvents are not sufficiently dry, the removal of water from them can be carried out using known methods, including azeotropic distillation and the use of desiccants, for example, alumina, sypicahep, anhydrous calcium sulfate, etc. The quantity and ratio of reagents are not decisive. Prnmen5not from feiTOK sulphurous nucleophe of formula for example 1-5 mol. eq. sulfur nucleophile at 1 mol. eq. 3- (edyloxime type) -cephalosporin of formula |. Some heteroaryl thiols, as well as some ortho and phenylthiols of the formula lit, exist in the form of thions or in the form of tautomeric mixtures of thiol and thion. For example, the compound 2-m8til-1,3,4-thiadiaeol-5-thiol exists in the form of a tautomer, K-LL However, the proposed reaction goes with the indicated class of sulfur-containing nucleophiles, regardless of whether the reagent is in thiol or thionic form. Accordingly, it is an essential aspect of the invention to conduct a reaction using PDA thiones of thiop-thionic tautomers of the corresponding reagent. ; Distinctive features of the method. is that compounds of formula ii and ill are used as starting products or, if Rj is an amidino-radical, a compound of formula II and thiourea, and the process is carried out with a water content of less than 5% by weight of the products, their released components are pharmaceutically acceptable salts can be used to control feces in warm-blooded mammals when given in parenterally with non-toxic doses (10-500 mg / kg body weight). Preparations of the compounds are made by conventional methods. In each of the examples presented, the Karl-Fisher method is used, which confirms that the solvent used contains less than 2% by weight of water. , EXAMPLE 1. Preparation of 3- (l-Mq thyl-1H-tetrazol-5-yl) -thiometry l-7-2- (2-thienyl) -acetamido-3-cephem-4-carbon acids in acetonitrile. 2.2 g (5.5 mmol) of 7- 2- (2-tienip) -acetamido-cefaposporanic acid and 1, O g (8.6 mmol) of 1-methyl-1H-tetrazole-5-thiol are added to 25 ml of aaetoni ripa in a flask equipped with a backflow coping of NIKOM with a drying tube, coAepw our anhydrous potassium sulphate (trade name is Yarierit). The reaction mixture is heated by reverse distillation with npi stirring, the progress of the reaction is followed by thin-layer chromatography. After reverse-distillation within 90 min by thin layer chromatography, the mixture contains about 2/3 of the original cephalosporanic acid and 1/3 of the desired product, after 3 h it is 1/3 of the original cephalosporanic acid and 2/3 of the desired product. After 6 hours, the reaction is almost complete, then the reaction mixture is cooled to room temperature and allowed to stand overnight. The solvent is distilled off on a rotary evaporator, the remaining foamy residue is dissolved in 10 ml of ethanol. By adding dropwise 1 ml of dicyclohexylamine-. per 10 ml of ethanol, the product starts to precipitate as dicyclohexyl new salt, which after 15 minutes of stirring is separated by filtration. The isolated product is washed with 15 ml of ethanol, and the product is dried under vacuum at 40 ° C for 2 hours. 2.50 g (yield: 76.1%) of product is obtained, m.p. 183 t (decomp.). NMR, IR and thin layer chromatography of the product showed that the analyzes were identical with the same sample of the product obtained by a known substitution method in an aqueous medium. NMR (DM5O-YB: §3.52 (, 2 -CHj), 3.76 (S, 2, H2CO-NH -), 3.92 (S-, 3, tetrazole-CH), 4.35 (S 2.3, -CHi), 5.0 (d, l, CbH, 3-5 Hz, 5.55 ((1, .3 5 Hz, 3-9 Hz). 6.95 (d 2 thiofen H and 4-H, Zg3 Hz), 7T55 TTGG thiophene 5-H, Hz), and 8.75 (i, 1, 3 9 Hz). Example 2. Preparation of 3- (l-ilfethyl-1H-tetrazole- 5-yl) -thiomethyl-7g: 2- (2-thienyl) -acetamido} -Z-efem-4-carboxylic acid in acetonitrile 4.0 g (10 mmol) 7-12- (2-thienyl) -acetamido - “Ephalosporanic acid and 5.8 g (50 mmol) of 1-letyl-1H-tetrazole-5-thiol are heated by reverse distillation in 50 ml of dry acetonitrile, previously treated on anhydrous sulfonic acid (commercial) Amberlite 15) in a dry atmosphere for 8.75 hours. The reaction is monitored by thin layer chromatography, it ends at the end of the 8.75 hour period. The solvent is distilled off and the residue is added to 125i MP of ethanol. 6 ml of shislohexipamine are added 75 mp of ethanol, with npoinyKT falling as dicycloxylamine salt. It is separated by filtration and dried. 4.5Og is obtained (yield 71%). NMR, IR and thin layer chromatography are identical to anapises for an authentic sample obtained by iodine replacement. NMR anapis is identical to NMR anapiz of the product from Example 1. Example 3. Preparation of 3- (1-methyl-1H-tetrazole-5-ip) -tyometype -7-2- (2-thienyl) -acetamido -3-cephem -4- carboxylic acid in 1,2-dichloroethane. 2.0 g (5 mmop) of 7- (2-thienyl-acetamido) -cephalosporanic acid and 1.2 g (10 mmop) of 1-methi -1H-tetrazole-5-thio-pa in 25 ml of 1,2-dichporethan boil with reverse distillation in a dry atmosphere for 5.5 hours. The solvent is distilled off on a rotary evaporator and 2.5 ml of ethanol is added to the filtrate, then a solution of 2 m of dicyclohexyl-amine in 25 ml of ethanol is added dropwise. The product crystallizes as dicyclohexylaminoia, stirred for 20 minutes at room temperature, then filtered, washed with 25 ml of ethanol and dried at 4 ° C in vacuo. 2.34 g of a solid substance, a white colored, is obtained (yield: 73.8%). IR and NMR analyzes are identical to the analyzes for an authentic sample obtained by aqueous substitution. The NMR spectrum is also identical to the product spectrum from Example 1, Example 4. Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7-amino-3-cephem-4-carboxylic acid in 1,2- dichloroethane. 3.0 g (10 mmop) of 7-formamido cefalosporanic acid and 2.4 g (20 mmol) of 1-methyl-1H-tetrazole-5-thiol. 50 ml of 1,2-dichloroethane is refluxed with stirring for 7 hours. The reaction mixture is then cooled to room temperature and allowed to stand overnight at room temperature. A reddish, gummy solid falls out. The product is identified by the removal of 7-formyl rjjvnnbi. The solvent is distilled off on a rotary evaporator and the residue is dissolved in 25 ml of methanol and 2.8 conc. NSBIs allow it to stand overnight at room temperature. The solution is then diluted to 50 ml with water and the pH is raised from 0.9 to 3.6 by adding triethylamine dropwise. Light brown Kristaply filtered, washed with water and dried; 2.10 g of product (65% yield) are obtained, the NMR spectrum is identical with the same product obtained by substitution. NMR (LPO, NaHCOi): S3.65 (ty 2.2-CHg.) Zd-16.5 Hz), 4.08 (S 1, -CH J with tetrazole), 4.16 ((2.3- CHj-WI - 12.5 Hz), 5.05 (L 1.3–5 Hz) and 5.45 (d, 1, Su-H) Hz). Example 5. Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7-f2- (2-thienyl) -acetamido-3-cephem-4-carboxylic acid in isopropyl acetate. 2.0 g (5 mmol) of (2-thienyl) -acetamido-cefalosporanic acid and 1.2 g (10 mmol) of 1-methyl-1H-tetrazole-5-thiol in 25 ml of isopropyl acetate are heated at reflux to EEC for 23 h. Then the reaction mixture is cooled to room temperature. Thin-layer chromatography showed that some amount of the original cephalosporanic acid remained. The light creamy solid is filtered, washed with isopropylacetate and dried. 1.60 g (yield 70.8%) of the product is obtained. JAAR analysis confirms the identity of this prodZTsta and shows the presence of less than 1% of the original cephalosporanic acid. NMR spectrum (DM5 O-le): 83.72 (S2,2-CH), 3.80 (S 2-CHiCON H-), 3.05 (S 3-tetrazole-CH3), 4.30 ( S2.3-CHj.)), 5.10 ((. 1, Sat-H, 3 5 Hz), 5.70 (g 1, 3, 5 Hz, 3-5 Hz, 3 8 Hz), 6 , 92 (d 2, thiophene 3- and 4-Н, 3 3 Hz), 7.15 (t 1, h thiophene 5-Н, 3-3 Hz) and 8.78 (d 1, -CHACON —N- , Hp) .-. Example 6. Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7-2 (2-hyenyl) acetamocyro-3-cephem-4-carboxylic acid in propionitride 2.0 g (5 mmol) of (2-thienyl) acetylamide-cephalsporanic acid 1.2 g (1 O mmol) of 1-1-letyl-1H-tetraol-5-thiol are boiled and refined in 25 ml dry propionitrile (97 ° C) until a thin layer romatograph showed no cephalosporanic acid sponge (45 hours). Then the reaction mixture was cooled to room temperature and the solvent was distilled off on a rotary evaporator: a solution was lost due to emissions. The residue was dissolved in 35 ml of thermal ethanol and 2 ml of dicyclohexylamine was added in 1O MP ethanol. The product precipitated out as dicyclohexipamine salt is stirred at room temperature for 10 minutes, then filtered, washed
    ethanol and dried. 1.24 g of product are obtained (yield 39%, not counting the product lost in the rotary evaporator). The NMR spectrum of this product is identical to the spectrum of the product from example 1.
    Example 7. Preparation of 3- (l Methip-1H-tetrazol-5-tIl) -myomethyl-7-2- (2-thienyl) -acetamide (-3-cephem-4. -Carboxylic acid in acetonitrile with added acid 3,5-dichlorophenyl phosphate.
    2.0 g (5 mmol) of 7- (2- (2-thienyl) aa-amido-cephalosporanic acid and 0.87 g (7.5 mml) of 1-methyl-1H-tetra-el-5-thiol and 0.122 g (0, The 5 mmol) acidic phosphate of 3,5-dichlorophenyl is heated overnight in 25 ml of dry acetonitripe at 70 ° C. Then the solvent is distilled on a rotary evaporator to 8-10 ml. At the same time, the product begins to crystallize. 25 ml of isopropyl acetate are added for 5 hours for further cristappization. After further stirring for another 0.5 h, the product is filtered, washed with isopropyl acetate, and dried. product (yield 43.4%). The NMR spectrum of the obtained product is identical to the spectrum of the product from example 5.
    Example 8. Preparation of 3- (1H-tetrazol-5-yl) -thiometho -7-2- (2-thienium l) -acetamido -3-cephem-4-carboxylic acid in acetic acid.
    2.0 g (5 mmol) (2-thienip) -acetamido-cefalosporanic acid and 0.87 g (7.5 mmol) of 1-methyl-1H-tetrazole-5-thiol are added to 25 ml of glacial acetic KHcnotbi. The reaction mixture was heated to 6 ° C and kept at this temperature for 1 hour. Thin layer chromatography showed only traces of the product. The reaction mixture is heated to 80 ° C and maintained at this temperature for 5 hours. The reaction mixture is then allowed to stand overnight and the product is filtered, washed with acetic acid and dried. About 71 g of product is obtained (yield 31%). The NMR spectrum of the product is identical to the spectrum of the product from example 5.
    Example 9. Obtaining 3- (4,5-dihydro-b-hydroxy-4-methi L-5-OXO-1,2,4-triazinyl) -thiomethyl-7-2- (2-thienyl) - "cetamido -Z-cephem-4-carboxylic acid in acetonitrile.
    2.0 g (5 mmol) (2-thienip) - shchetamido-cephalosporanic acid. And 1.2 g (7.5 mmol) 4,5-dihydro-6-ok - -4-motil-5-oco-l , 2, 4-triazin-Z-thiol
    25 ml of dry acetonitrile are added in a reaction flask immersed in an oil bath at 84-85 ° C. The flask is equipped with a reflux condenser with a drying tube containing anhydrous calcium sulfate. The reaction mixture is kept under these conditions for 16 hours with slow stirring with a magnetic stirrer. The product crystallizes from the hot solution. Then the reaction mixture is cooled to room temperature, filtered, washed with acetone and tripium, then with acetone and dried in vacuum. 1.81 g of product is obtained (yield 72.6%). The melting point of crystals is gr of a white color ((decomp.).
    When standing, the second batch of crystals falls out of the filtrate. They are filtered, washed with acetonitrip and dried. 0.26 g is obtained (yield 10.5%). product. The melting point of these crystals is also 161 ° C (decomp.). Total yield 83.1 Example 10. Preparation of 3- (5-methyl / 1, 3,4-oxadiazol-2-yl) -thiometry | 2- (2-thienyl) -acetamido3-3-cephem of 4-carboxylic acid in 1 , 2-dichloroethanol.
    2.0 g (5 mmol) (2-tienip) acetamide se-cephalosporanal yuloty and 0.87 g (7.5 mmol) 5-methyl-1,3,4-oxadiazol-2-thiol in 25 ml 1, 2 dichlo {ethane is loaded into a flask equipped with a magnetic stirrer and a reflux cooler with a drying tube containing anhydrous calcium sulfate. The flask is placed in an oil bath at 84-85 ° C and kept in the bath for 8 n /, then cooled for two days. A part of the product crystallizes, is filtered off, washed with 1,2-dichloroethane and dried. 1.1 g (yield 48.7%) of product are obtained. The product is dissolved in 15 ml of acetone and filtered to remove insoluble products. Purification of insoluble products is then added dropwise. Then 75 ml of deionized water is added dropwise and the product is filtered and dried. Obtain 0.61 g of product with m. P. (different)
    Distillation of the solvent from the filtrate gave O, 23 g of a mixture of the product and both starting materials.
    Example 11. Preparation of 3 - {1-methyl-1H-tetrazole-5ng1p) -thiomethyl-7-12- (2-tnenyl) -acetamido-3-h-peph-4carboxylic acid in nitromethane.
    2.0 g (5 mmol) (2-tienip) -acetamido3-de-spalosporanic acid
    and 0.87 g (7.5 mmop) of 1-metip-1H-tetraeop-5-thiop is added to 25 mp of dry nickel in a cobbe submerged in an oil bath at 1OO-110C 4.5 hours 5 then cool the copba to room temperature. Thin layer chromatography indicated that the reaction was complete.
    The solvent is distilled off on a rotary evaporator, the residue is dissolved in 75 ml of 10 ml of thermal ethyl acetate. The solution is filtered to remove a small amount of insoluble substances, then extracted with two portions of 25 ml of 5% aqueous solution of aqueous sodium bicarbonate. 15 The combined extracts are layered with 50 ksh of ethyl acetate and acidified to pH-1, O 7 O% aqueous methane, sulfoxide. The ethyl acetate layer is separated, the aqueous layer is extracted with 2.5 MP 20 of ethyladylate. The ethyl acetate layers were combined, dried over anhydrous sodium sulfate, and evaporated to 25 ml on a rotary evaporated & l. After adding dropwise 5 O ml of diethyl ether, the product 25 crystallized. It is filtered, washed with diethyl ether and dried. Produce 1.27 g of the product (56.2%) gr of white-colored crystals with m. Pl. 156159 C (decomp.). The identity of the product is confirmed by NMR analysis.
    Example 12. Preparation of 3-1 (1-methyl-1H-tetrazol-5-yl) -thiomethyl) -7-2- (2-thienyl) acetamido-3-cephem-4-carboxylic acid in methylene chloride. jj
    11.9 g (30 mmol) (2-thienyl) -aietamido-1-phalosporanic acid and 7, O g (6O mmol) -1-methyl-1H-tetrazol-5-thiol in 300 ml of methylene chloride (stabilized by cyclohexane) are loaded in a 1 liter stainless steel autoclave equipped with a heater.
    The reaction mixture is stirred and heated at 83-86 ° C, while creating a pressure of 42 psi (. 9 bar) for 16 hours. The reaction mixture is then cooled to room temperature. Thin-layer chromatography showed complete conversion to the target product, containing only traces of the original cephalosporanic acid. The reaction mixture is allowed to stand at room temperature (the product crystallizes), then it is evaporated to mp. Cristaps were filtered and washed with methylene chloride RIDOM, to give 7.37 g (yield 54.3%): white crystals with m.p. 163.5-164 0 (decomp.).
    A second portion of light brown crystals is obtained by diluting a solution of 1OO ml of diethyl ether, filtered, washed with diethyl g-fir and dried. Get more than 1.4 g (10.3% yield). The third portion of crystals is obtained by diluting the filtrate with isopropylacetate, in an amount of 1.18 g (yield 8.7%). The overall yield is 73.3%.
    Example -13. Preparation of 3 -1 (1-methyl-1H-tetrazol-5-yl) -thiomethi1 | -7-2- (2-thienyl) -acetamido-3-cephem-4-carboxylic acid in fluorobenzene.
    2, O g (5, X) 4 mmol) (2-thienyl) -acetamide-cephalosporanic acid and 1.2 g (10 mmol) of 1-methyl-1H-tetrazole-5-thiol in 75 ml of fluorobenzene (so boil 85.1 C) are mixed in a flask equipped with a reflux condenser with a drying tube containing anhydrous calcium sulfate. The mixture is heated by reverse distillation; the course of the reaction is followed by thin layer chromatography in ethyl acetate / acetic acid 7/1. The reaction in a heterogeneous medium is completed in 7 2 h. Then the reaction mixture is cooled to room temperature and filtered from the precipitated product. The product was washed with fluorobenzol and dried under vacuum at 40 ° C for 5 hours. 2.13 g (yield, 93.4%) of off-white crystals were obtained with mp. 161-162 C (decomp.). The identity of the product is subjected to NMR analysis.
    EXAMPLE 14. Preparation of 3- | (1-methi-1-H-te-trazo-5-and l-thiome-ty -4carboxylic acid in thiophene.
    2, O g (5 mmol) 7-12- (2-thienyl) -acetamido3-cephalosporanic acid and 0.87 g (7.5 mmop) of 1-methyl-1H-tetrazole-5-thiol in 125 ml of thiophene are boiled t under reflux for 7 hours, during which time the product crystallizes. The reaction mixture is cooled to room temperature, stirred for 30 minutes to complete crystallization and filtered. The isolated product is washed with 0.5 ml of thiophene and dried under vacuum for 2 hours. G (yield, 80.2%) white crystals are obtained with a temperature of 162-162 ° C. (dec.). Thin layer chromatography showed that the filtrate contained an additional amount of product.
    Example 15. Obtaining 3- (5-methyl-1, 3,4-thiadiazop-2-41l) -thiometype | „7-G2-1H-getrazop-1-ip) -acetamido-3-cephem-4-carbonic acid in acetonitripe. O, 76 g (2 mmol) (1H-tetrazop-1-un) -acetamido-Ch1 efaposparonic acid and 0.33 g (2.5 mmop) 5-methyl-1, 3,4-tkadiaeop-2-thiopa in 1O The mp acetonitripe of the reactive grade is boiled under reflux for 2 hours and 4 minutes. Product kristappieets. The reaction mixture was cooled in an ice-bath and filtered to isolate the product, which was then washed with 3 ml of acetonite and dried at 4 ° C in vacuo. 0.61 g (67% yield) of product is fed. The identity of the product is confirmed by the NMR spectrum: S 2.68 {S3, -CHj tetrazopa). 3.72 (S2.2-CH2.), 4.4O (OL 2.3-CHi S3 13 Hz), 5.12 (d 1, Cj-H Hz), 5.38 (S2-CHJ.ONH- ), 5.72 (, CpH, J: 5 Hz) Jr 9 Hz), 8.00 (S 1, tetrazopy 5-H) and 9.17 (U 1, -CH., CONH-) .. Example 16 Preparation of 3- (1-g-methyl-1H-tetrazol-5-yl) -thiomethyl-7- (2-formyloxy -2-pheny-lacetamido) -3-cephem 4-carboxylic acid in 1,2-dichloroethane. 2.17 g (5 mmop) of 7- (2-formyloxy-2-h}) enipetacetamido) -cephalosporic acid and 0.87 g (7.5 mmol) of 1-metip -1 H-tetrazole-5-thiol are added to 25 m of 1,2-dichloroethane and the obtained reaction mixture is boiled under reflux} {lump for 6 hours. After 3 and 6 hours, samples are taken for analysis by thin-layer chromatography. Then the reaction mixture is heated for another 1 h, then it is cooled overnight. The solvent is distilled off, diethyl ether is added to the residue, which, at first, gives a gummy and then a solid. The product is separated by filtration, washed with diethyl ether and dried. 1.9 g (77% yield) of product is obtained. NMR spectrum (DM $ O-a): 8 3.52 (S2,2-CHi), 3.88 (S3, -CH tetrazope), 4.10 (5 2.3-CH., - S-) r 4, 92 (d 1, Sat-H), 5.62 (tj, 1, C; -H, 3 5 Hz, -3-9 Hz), 6.06 (5 1, -СИСО "Н-), 7, 26 (S5, phenyl H) and 8.28 (S1, -OCH). Example 17. Preparation of 3-Gl-methyp-1H-tetrazop-5-yl) -thiometig -7- | 5-carboxy-5- (2 , 4-dihporbenzamido) -valeroamido-3-cephem-4-carboxylic acid in: a) aceotonitrile and in J., 2-dichloroethane. 96141 a) 2.9 g (5 mmol) of 7-15-x.rboxy .5- (2,4-dihporbenzamido) -valeroamido} cephalosporanic acid and 1.2 g (10 mmol) of 1-metip-1H-tetrazole- 5-tyoa and 50 MP of acetonitrile are boiled with distillation distillation overnight 1 (18h). by chromatography chromatography set the reaction to about 90%. The loan is evaporated and the residue is suspended in ethyl acetate and ilt. 1.51 g (yield 48.3%) of product are obtained. 6 2.9 g (5 mmol) 7-jB-carboxy-5- (2,4-dichlorobenzamido) -valeramide | cephalosporanic acid, 1.2 g (10 mmol) of 1-methyl-1H-tetrazop-5-thiol and 5O MP of 1,2-dichloromethia are refluxed for 5.5 hours. Thin layer chromatography showed a conversion of 9O%. The solvent is decanted in the reaction mixture, the remaining solid paste-like residue is triturated with B and refluxing the ether. Then, the product is separated by filtration, and 2.83 g (yield: 89% -3%) of brown crystals are obtained. The NMR spectrum showed the identity of the product as well as the presence of ether.r NMR (flMSO-dg): 01.78 and 2.26 (each with TP and a side chain), 3.36 (ni2.2-CH2,), 3.95 (S3, - CH tetrazopa). 4, ZO (tp2,3-CH), 5, O8 (il, СБ-Н, 3-5 Hz, 5.68 (С |, 1, С7-Н,. Лг5 Hz), 7,5О and 7, 62 (each & 2,4dichporpenip) - and 9, OO (t2, two-SONH-). Example 18. Preparation of 3- (1-mti n-1 H-tetrazo-p-5-l) -thiome n -7- - 2- (tienip) -aietamido) -3-cephem-4-carboxylic acid in 1,2-dichloroethane. - 0.99 g of (2-thienyl) -acetamido-cefaposporanic acid and 0.58 g (5 mmol) of 1-methyl-1H-tetrazol-5-thiop are added to 12.5 ml of 1,2-dichloroethane and the reaction mixture reflux to remove acetic acid byproducts. For this, the reflux of 1,2-dichloroethane flowing down is passed through calcium oxide. After such heating of the reaction mixture for 5.75.4, it is cooled to room temperature and filtered. The fluffy midday needles are washed with 10 ml of 1,2-dichloroethane and dried to obtain 0.77 g (68.1% yield) of the product. After evaporation of the filtrate, more than 0.04 g of product is obtained (yield 3.5%). The identity of the product is confirmed by thin layer chromatography and in the case of axial portions of the product by NMR spectrum, which is identical to the NMR spectrum of the product from example 5, Example 19. Preparation of 3- (5-methyl-1 .3 .4-thiadiazop-5-sp) -tyomer ) -7-G2- (2-tienigt) -acetamido-3-cephem-4-carboxylic acid in acetonitrile e. 2.0 g (5 mmol) of 7- (2-tienip) -acetamido3-cefaposporanic acid and 2.64 g (20 mmol) of 5-metip-1,3,4-thiadiazop-2-thiol in 25 mp acetonitri pa It is heated by reverse distillation overnight at 79 C. After this, this is a compound. The chromatography showed only the decay of the starting cefaposporanic acid. The reaction mixture is filtered to remove oily residue; the solvent is distilled off on a rotary evaporator. The residue is crystallized from acetonitripe: isopropyl acetate (1: 1). separated by filtration, washed and dried in vacuo. 1.59 g (yield 33.9%) of product are obtained with mp. . The identity of the product is confirmed by IR, UV NMR and mass spectra, as well as by elemental analysis. NMR (DM20-Yb): $ 2.68 (S3, -CHj tetrazole), 3.68 (S2, 2-CHj), 3.76 (S2, -CHj COMH-), 4.38 (cj, 2, 3 -СНг S-, 3 13 Hz), 5.10 (o11, CbN Hz), 5.70 (with |, 1, Su-N, 3 -5 Щ,; 9 Hz), 6.92 ((3 2 , thiophene 3rd 4-H), 7.37 (tl, thiophene 5-H), and 9.10 (d. 1. -CHj CONH-), Hz). Example 20. Obtaining 3- (1-meth11-1H-tetraz6l-5-yl) -thiomethyl. -7- 2- (2-thienyl) -aiyamido-3-cephem-4-carboxylic acid in 1,1,2- trichloroethane. 2.0 (5 mmop) (2-hyenip) -acetamido} -chefalosporanic acid and 1.2 g (10 mmol) of 1-methyl-1H-tetrazole-5-thiol are added to 25 mp of 1.1.2 trichloroethane and heated at 1OO 101 C. The progress of the reaction is followed by thin layer chromatography; after 4 h at this temperature with stirring, the thin layer chromatography did not show the appearance of the original cephalosporanic acid. Then the reaction mixture was cooled to room temperature with stirring, seeded, and continued to stir overnight. After that, the product is cristaped, the solvent is distilled off and 25 ml of 1,2-dichloro ethane is added. The solvent is again separated by filtration, the product is washed and dried under i-vacuum. Obtain 0.98 g (yield 43.4%) 3 1 -meth p-1 H-tetrazo L-5-And p) -tyometype} -7-2- (2-thienyl) -acetamide J-3-cephem- - 4-carboxylic acid with m. PL. 158 C (decomp.). Example 21. Preparation of 3-C (1-methyl-1H-tetrazog 5-ip) -thiomethi -7-2- (2-thienyl) -acetamido-3-cephem-4carboxylic acid in: methyl ethyl ketone and 1.1, 2-trichloroethane. a) 2.0 g (5 mmol) of (2-thienyl) -acetamido-cephalosporanic acid and 1.2 g (10 mmol) of 1-methyl-1H-tetrazop-5-thiop are added to 25 ml of methylethipketone and heated to the reverse distillation within 48 hours. Thin-layer chromatography showed that only traces of the original cephalosporanic acid remained. The reaction mixture is washed with 2.5 g of sodium bicarbonate and 50 ml of water. The aqueous layer was treated with 21 g of activated carbon and 5O ml of ethyl acetate was added. The pH of the solution is reduced to 1.6 by adding 4 ml of metipsuptoacid in 30 ml of water. The ethyl acetate layer is dried with sodium sulfate and evaporated to an oil on a rotary evaporator. The product is crystallized by adding dropwise 50 ml of ether. The product is filtered, washed and dried under vacuum. . 0.94 g (yield: 41.6%) of the product is obtained. The NMR spectrum is identical to the spectrum of the product from Example 5. O) The reaction is repeated with the starting materials in part a), but the solvent used is 50 ml 1,1,2-trichporethane. The reaction mixture is heated by reverse distillation for 16 hours. At the end of this period, thin layer chromatography showed the absence of starting cephalosporanic acid. The product is isolated as in part a) to obtain 0.47 g of the product (yield 20.8%), the NMR spectrum is identical to the product of Example 5. Example 22. Preparation of 3- (1-methyl-1H-tetrazol-5-yl ) -thiomethyl-7- (2-. -phenylacetamido) -7-methoxy-3-cephem-4carbric acid in 1,2-dichloroethane. 210 mg (0.5 mmol) of 7- (2-h}) enylacetamido) -7-methoxycephalosporanic acid, 87 ml (0.75 mmol) of 1-methyl-1H-tetrazrl-5-thiol, and 15 ml of 1,2- dichloroethane is heated together by reverse distillation for 6 h in a nitrogen atmosphere. By this time, thin layer chromatography showed only traces of the original cephalosporanic acid. Another 29 mg (0.25 mmol) of 1-methyl1791 -IH-tetraeop-5-thiopa are added and the reaction mixture is heated by refluxing for 3 more hours. Thin layer chromatography showed no noticeable changes. The reaction mixture is then washed four times with a saturated solution of sodium sarbonate; then the bicarbonate solution is washed three times with etipapetatom, a small amount of fresh ethyl acetate is added, cooled to and adjusted to pH 2.2 with 2 O% HCt. The layers are separated, the aqueous solution is washed with ethyl acetate. The acetate spheres are combined, washed with a saturated solution of sodium chloride, dried over magnesium hydroxide over the soup, filtered and evaporated. A light green foamy residue is obtained in an amount of 199 mg (yield: 83.6%). The identity of the product is confirmed by fine-chemical chromatography and an NMR spectrum. J1MP (CETS +1 d acetone-a b): SU 3.45 (S3-OCHi), 3.55 (S2.2-CH2). 3.75 (S2, CH5LCO-), 3.9 (S3, CH tetrazopa), 4.4 (52.3-CH S-) 5.15 (S1, Sat-H), 7.35 (55), 8.0 (S1, -CH2.CONH-) and 11.2 (S1, Hz, -COOH). Example 23. Preparation of 3- (2-benzothiazoptylotype) -7-12- (2-thienium l) -acetamido-3-cephem-4 -carboxylic acid in 1,2-dichloroethane. 1.0 g (2.5 mmol) (2-thienip) -acetamido-cefapesporanic acid and 0.625 g (3.75 mmop) of 2-mercaptobenzothiazole are charged into a flask whose air is displaced with nitrogen, 25 MP 1.2 are added. -dichloroethane and the reaction mixture is heated by reverse distillation for 24 h while moving the NI. The reaction mixture is cooled and filtered. 1.1 g (yield 88%) of the product is ash-white in color with m. M. 190.5-191 C (razp.). It exists overnight at a vacuum, analyzed. The identity of the product is confirmed by NMR, UV, mcc spectroscopy, IR spectra and elemental analysis of NMR (DM b 3.74 (S 2 .2-CH2), 3.80 (52, H -), 4.58 cm2. 3 -CH Hz), 5.14 (and 1, in-N, Jh5 Hz), 5.73 (O, 1, C7-H, 3 Cg-H, Jh5 Hz), 5.73 (q, 1 , C; 5 Hz, 1: 8 Hz), 6.96, 7.43 and 7.96 (each TP are phenyl and thienyl rings), 9.1 O (d 1, -CHiCONH, Hz). Example 24. Preparation of 3-t (5- -methylacetamido-1, 3,4-thiadiazot-1-2-un) -thiometyp-7-2- (2-thienip) acetates o) -3-cephem-4-carboxylic acid in 1,2-dichloroethane. 2, O g (5 mmop) 7 (2-tienip) acetamido-cefaposporanic acid and 1.42 g (7.5 mmop) (5-H-methylamino-amide) -, 3,4-thiadiazop-2-thiol are added to 5O MP dichporethane and the reaction mixture is heated by reverse distillation for Yu h. Then the reaction mixture is cooled, filtered, washed with 1,2-dichloroethane and dried in vacuum. Accept 2.06 g (78.3%) of the product with m. PP, 1781 9 ° C. The identity of the product is confirmed by IR, UV and NMR analyzes, mass spectroscopy and elemental. by analysis. NMR CuMSO-dk): O 2.42 (& 3, -COCH,) 3.74 tp 7, 2-CHg. -CH, tetrazopa and -CHj CONH-), 4.35 (t |, 2, W-CH, 3 13 Gi). 5DO (and 1, 3-5 Hz), 5.70 (1, C7-H, 3 5 Hz: i: 9 Hz). 6.96 and 7.36 (each tpz, thiophenic H), and 9.1O ((3 1, -CH2.CONH-, 0: 9 Hz). Example 25. Preparation of 3- (1-.-Methyl-1H -tetrazo-5-yl) -tyometype (C-tert-butoxycarbonyl-2-phenipgp cylamido) -3-cephem 4-carboxylic acid in 1,2-dichloroethane. 45 MP 1,2-dichloroethane is heated with reverse distillation dp purification it is water-soluble from acetopic acid, then distilled to 30 MP and allowed to cool. Add 253 mg (0.5 mmop) of 7- (M-t-tert. -Buthoxycarbonyl-2-pheny pp pycido pamido) to the solution and distill the solution to 15 ml and cool again. 87 mg (0.75 mmopi) of 1-metip-1H-tetrazop-5-thiopa are added to the mixture and the reaction mixture is heated by reverse distillation under nitrogen atmosphere, the course of the reaction is checked by thin layer chromatography. Chromatography showed only traces of starting material. The reaction mixture was washed with four P with a saturated solution of sodium bicarbonate in water, the bicarbonate chunks were combined together and washed twice with ethyl acetate. To the washed bicarbonate layers, fresh etipacetate is added, the solution is cooled to OC and the pH is adjusted to 2.4 2 O% HCl. The solution is separated, the aqueous solution is washed with etilacetate. These ethyl acetate layers were combined, washed with a saturated sodium chloride solution, dried over magnesium sulfate, filtered and evaporated. I get free. I give foam in the amount of 224 mg (yield: 8O%). The identity of the product is confirmed by thin layer yumatografiia and NMR, which showed the presence of a small amount (10%) of the original cefaposporanic 1-1slot. This product is suspended in 1O ml of diethyl ether and triturated for 1 hour. The ether is decanted and 10 ml of fresh diethyl ether are added and triturated for 1 hour. 1 h. The ether is decanted and evaporated to dryness. Get the product in the form of a white powder. The identity is confirmed by thin-bed chromatography and YMR-valenie. NMR (); S 1.45 (S9-COO-. -Tr-C Nd), 3.6 (52.2-CHg), 3.95 (S3. CH J tetraeol). 4.3 (S2, 3CHjS). 4.9 (ril. Hz). Cg-H) .5.4 (I 1. a-8. Hz, CH-), 5.75 (and 1. About 4 Hz. CV-H), 6.2 (a 1. 3: 8 Hz. At J 7.4 ( S5) .7.65 (dl.3 8 Hz. W IT -CONH). And 9.3 (Si, -CoRH), Example 26. Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiometig -7- (S-tert-butoxycarbonyl-2-t-oxyphyl or lt-p-lamido) -3-cephem-4-carboxylic acid in 1,2-dichloroethane. 45 ml of 1,2-dichloroethane are heated with a trap and removed 15 ml of solvent. The remaining 30 ml are cooled. 26 O, 5 mg (0.5 mmop) of 7- (N-tert-byproduct; oicarbonyl-2-11-oxyfone or pyricamido) -Tsef1Ph: poranic acid and solution are added. further distilled to 15 ml and cooled again. 87 mg (0.75 mmol) of 1-methy11-1H-tetrazo1-5t are added The iola and the reaction mixture are heated to 65-7 ° C and the reaction is followed by thin layer chromatography. A 3-hour thin layer chromatography showed 1104 total absence of the initial substance and the reaction mixture is processed after 4 hours. The treatment and purification is the same as in the previous example. is 189 mg of crude product (65.5%) and 46 mg of purified product (16%). NMR spectrum (CDS + 2 acetone-flg): S 1.45 (S9, -COO-type v. ScHH3, 35 (S2.2-CH2) 3.85 (S3, single-phase CH) 4.3 (S2, 3-CHiS) 4.9 (3.1, Hz. Sa.-gSH, 5.3 (“i ,, la 3 Hz. Su-N) 5.4 (.Sjl BUT-SJ-n), 5.75 (S, 1. GHgd , NOSI), 6.4, -1- $ ts1. COOH), 6.8 (d, 2, II. UTIl 7g8 Hz, .9 (1, -Sa "GN Example 27. Getting 3 (1,2,4- oxadiao-5-yp) -thiometype -7-p- (2-thienyl) -acetamido-3-cephem-4-carboxylic acid in 1.1,2-trichloroethane .396 mg (1 mmol) (2-thienyl) -acetamido -cephalosporanic acid is suspended in 4O ml of 1.1,2-trichloroethane and 116 mg (1 mmol) of 3-methyl-1,2,4-oxadnazop-5-thiol is added. The reaction mixture is heated at 113 ° C in an oil bath in for 3 h, for It is allowed to cool overnight and evaporated to an oil. Ethyl acetate and a saturated solution of sodium bicarbonate in water are added. The ethyl acetate portion is washed again with a saturated solution of sodium bicarbonate in water and the aqueous parts are combined and extracted again with ethyl acetate. ethyl acetate. cooled in an ice bath, -pH adjusted to 2.5% 2O% HCt. The layer was removed and the aqueous layer was extracted again. The ethyl acetate layer was washed, combined with a saturated solution of sodium chloride in water, dried over magnesium sulfate, filtered and evaporated. 1,1,2-Trichloroethane is added to the residue, after which a solid PRODUCT is formed in an amount of 22O mg (yield 48% y. The identity of the product is confirmed by NMR, IR, UV-analyzes and a biogram. NMR (DM50-ib): 2, 35 (, & 3, -CH3 oxadiazole), 3.7 ((y2, Hz, 2-CH2), 3.8 (S2, -CHjCONH-), 4.4 ("y.2.3 14 Hz, 3-CH2 &-). 5.1 (a, 1.3-5Gi, Sat-H), 5.6 (1.1, 3 4 Hz, q - H). 6.9, 7.3 ( g, and thiophenic H), and 9.1 (3 1. L :: 8 Hz, -eNz SOMN-). Example 28. Preparation of 3-t (lH-1, 3,4-triazo-5-yl) -thiometype) -7- - (2-thienip) -detamido-3-cephem-4-carboxylic acid in 1,1,2-trichloroethane. 396 mg (1 mmop) (2-thienyl) "cetamides -1ufususporanic acid is suspended in ZO ml 1,1,2-trichloroethane and 1 Omg (1 mmol) of 1H-1,3,4-triazol-5-thiol is added to the suspension. The reaction mixture is heated and after about 30 minutes the product is precipitated. then the reaction mixture is cooled to room temperature. The product is collected by filtration and washed with 1,1,2-trichloroethane to give 380 mg (yield 87%) of the product. The identity of the product is confirmed by IR-NMR, UV-analyzes and a bovutogram. The bioautogram also shows the presence of starting cefaposporana acid, the amount
    which according to liquid chromatography under pressure is 6.8%.
    NMR (): f3.7 (S2, 2-CH). 3.8 (S2, -CHj COMH-), 4.2 (2.3 5 Hz,), 5.1 (d 1.0r5 Hz.
    Cg-H), 5.7 (q, l, 3: 4 Hz. Cy-H), 7.0, .7.4 (t, d, 3. Thiophenic H). 8.45 (S 3. triazopny WH). and 9.13 (4,1.3 8 Gp; -CH CONH-).
    Example 29. Preparation of 3- (1-metip-1H-tetraeop-5-yl) -thiometry; 3 -7- (2-fene-laceta to) -3-cephem-4-to arbonic acid in chloroform
    195 mg (0.5 mmol) of 7- (2-phenylacetamido) -nonfalosporanic acid are suspended in 75 ml of chloroform and 75 ml (0.65 mmol) of 1-methyl-1H-tetrazole-5-thiol are added. The reaction mixture is heated in an oil bath at 80-85 ° C for 3 hours and 6O ml is distilled off. Thin layer chromatography showed a very small amount of product. 2 O ml of 1,2-dichloro-ethane is added and heating is continued overnight. Thin layer chromatography the next morning showed the presence of a very small amount of the original cephalosporanic acid. After 26 h of reaction, the reaction mixture is cooled to room temperature. The product is treated as in example 32, Obtain 80 mg (yield 35%) of purified substances. The identity of the product is confirmed by NMR, IR and UV analyzes and autobiogram ..
      (DM5O-oj): 3.6 (5,2,2-СНг. 3,7 (52, -CRj CONH-), 4,0 ($ CG tetrazope CHj,). 4.3 (S2, W-SNg.) , 5.1 (fll D 5 Hz. Sat-H): 5.7 (a, 1, 3 4 Hz. C7-H), 7.3 (S5), and 9.13 (Si 3 8 Hz. -CH SOMN -).
    Zo example. Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7- "cetamido-3-cephem-4-carboxylic acid in 1,2-dichloroethane.
    314 mg (1 mmol) of 7-acetamido cepha-posporanic acid and 98 mg (0.65 mmol) of 1-methyl-1H-tetrazol-5-thiop are mixed in 70 ml of 1,2-dichloroethane, 50 ml are distilled off and the reaction mixture t with reverse distillation within 24 hours. The reaction mixture is processed as in Example 32 and half-ohl 12O mg of product (yield 32%). The identity of the product is confirmed by NMR. IR, UV-assays and austobiogram.
    NMR (aMSO-ng): d 1.97 (S3. CH CpNH-). 3.7 (S2. 2-CHj). 4.0
    (S3. Tetrazole CHj). 4.35 (S2,3-.
    ). 5.1 (i, Hz, CgH), 5.7 (, 1.3 4 Hz. Su-H) and 8.8 (d, 1.3-8 Hz,
    wear H).
    Example 31. Preparation of 3- (3-methyl-1 .2.4-thiadiazol-5-ip) -thiometry -7-2- (2-thienip) -acetamido-3-cephem-4-carboxylic acid in 1,2-dichloroethane .
    20 O mg (0.5 mmop) (2.-thienium l) -acetamido 3-cephaloparanic acid and 85 mg (0.65 mmol) 3-methyl-1, 2.4-thiadiazole-5-thio. L are mixed in 50 MP 1, 2-dichloroethane and heated at 95 ° C in an oil bath. The bath temperature is maintained at 9 ° C for 19 hours. Then the reaction mixture is removed from the bath and allowed to cool in the refrigerator for a day. Then three volumes of ethyl acetate are added and washed with two portions of P9 with 50 ml of saturated sodium bicarbonate aqueous solution. The combined aqueous extracts are extracted with ethyl acetate, layered with fresh ethyl acetate and cooled in an ice bath. The pH of the medium is adjusted to 2.0. The layers are separated, the aqueous layer is again extracted with ethyl acetate. The combined ethyl acetate portions were washed with saturated aqueous EopoM sodium chloride, dried over magnesium sulfate, filtered, and evaporated to give 252 mg of foam. It is crystallized from a mixture of acetone, diethyl ether, to obtain 153 g of product (yield 65%). The identity of the product is confirmed by NMR. UV IR analysis and bioautogram.
    NMR (DM50-Av): 5 3.7 (52,2-СНг 3.8 (& 2-. -CHiCONH). 4.5 (а.2.3 15 Hz. 3-СНг5-). 5.1 (с1., 1. Hz, CS -H) .5.7 (1. Hz. C7-H) .6.96. 7.38 (tS 3, thiophenic H). And 9.13 (d, l. Hz.).
    Example 32. Preparation of 3- (2-pyrimidinylthiomethyl) -7- 2- (2-thienyl) -acetamido-3-cephem-4-carboxylic acid, you are in acetonitrile.
    2.0 g (5 mmol) (2-thienyl) - etamido - {{ёfaposporanovoy acid and 0.62 g (5.5 mmol) of 2-mercaptopyrimidine are mixed with 25 ml of dry acetonitrile and the mixture is heated by reverse distillation overnight (16 h) at stirring. Thin layer chromatography showed complete conversion to the product. The reaction mixture was cooled to room temperature and the product was isolated. by filtering. Then it is washed with 50 ml of acetonitripe and dried under vacuum at 50 ° C for 4 hours. 1.86 (yield, 83%, O%) of Cristapl-white color is obtained with m.p. 217 ° C (dec.). NMR in f-g showed no presence of starting material. The identity of the product is confirmed by infrared, ultraviolet, and NMR spectra. NMR (DM50-c) 8 3.55 (and, 2, 2CH2, 18 Hz), 3.74 (S2.) 4, -28 {Cf-t 2.3 -CHS S -), J sl3 Hz). 5, OO (I, 1, Sat-I.-5 Hz), 5.64 ((), 1. a-H J 5 Hz, E 9 Hz, 7.08 tp and 8.52 a (6, thiophenic and pyrimidine H) and 9, OO (d, l, -CHACON H- 3 9 Hz). Example 33. Preparation of 3- {2-pyrimnthylthiomethyl) 7-2- (2-thienyl) -acetamidoT -3-cephem-4 Carbric acid in acetic acid. 2.0 g (5 mmop) (2-thienyl) -acetamidoZ-cefapbespoic acid, 0.6 g (5.4 mmol) 2-mercaptopyrimidine, 0.41 g (5 mmol) sodium acetate in 25 MP ice guy acetic the acids are heated at 85 ° C for 4 hours. During the course of the reaction, the product crystallizes. The reaction mixture is then cooled to room temperature and the product: And 1 is filtered, washed with acetic acid and dried. Obtain 1.58 g (yield 70.5%) of white, kistappov with t.pr. 218 C (decomp.). To the identity, the product is confirmed by IR, UV and NMR analyzes and elemental analysis. The NMR spectrum is identical to that of the product from Example 37, Example 34. Preparation of 3- (1chietil-1H-tetrazop-5-yl) -thiomethyl -7-2- (2-thienyl) -acetamido -cefaporsporic acid in acetic acid. 2.0 g (5 mmol) (2-thienyl) -acetamido-cefalosporanic acid, 0.81 g (7 mmol) 1 - methyl-1H-tetra-, sol-5-thiod and 0.41 g (5 mmol ) sodium acetate in 25 ml of acetic acid is heated at 75-77 0 and kept at this temperature for 8 hours. Every hour “1” is analyzed by thin-layer chromatography, after 8 hours it has shown the completion of the reaction. The reaction mixture is cooled to 4 ° -45 ° C and the acetic acid is distilled off in vacuo. Then 50 mp of etipadhet and 50 ml of water are added to the residue. The aqueous layer is acidified to a pH of 1.5 with 1.0 N. A solution of sulfuric acid. The ethypapetal pool is separated, dried with anhydrous dried sodium sulfate and distilled on a rotary ispenthepte. The residue in a light IAS filter is dissolved in 50 MP of ethanol and a solution of 2 ml of dicyclohexylamine (10.2 mmol) in 10 ml of ethanol is added. The product precipitates almost immediately as a dicyclohexyl-amine salt, it is stirred for another 15 minutes, then separated by filtration, washed with ethanol and dried. Obtain 1.2 g (yield 37.8%) of the product with so pl. . IR, UV and NMR analyzes are identical to those obtained. Example 35. Obtaining 3- (1-benzyl-1H-tetrazol-5-and l) -thiometry l (2- (2-tienip) -acetamide 3 -3-cephem-4-carboxylic acid in 1,2-dichloroethane. 2.0 g (5 mmol) of (2-thienyl) -acetamido-cefalosporanic acid and 1.44 g (7.5 mmol) of 1-benzyl-1H-tetrazole-5-thiol were added to 5 ml of 25 ml of 1,2 dichloroethane and the reaction mixture heated to 85 ° C in an oil bath and kept at this temperature overnight with stirring. After this, thin layer chromatography did not show the presence of the initial cephalosporanic acid. The solvent is distilled off on a rotary evaporator and froth foam. 25 ml of methanol is added to the foam and the mixture is heated on a steam bath to dissolve the sample. The solvent is distilled off on a rotary evaporator and the product crystallizes. The mixture is stirred for 15 minutes, then filtered off, washed with methanol and dried in a vacuum. g (yield 6O, 6%) of the product with mp. 171-171 ,. Example 36, Preparation of 3: g diothiometyp-7-12 "(2-thieni l) -fadej-3-yephem-4- kvrbonovoy acid in acetonitrile. 3.12 g (8 mmls) of 7- (2-thienyl) -detamido-3-cephalosporanic acid and 912 mg (12 mmol) of tirmorea in 15 ml of acetonitrile (pre-dried in a silica-alumina digester — molecular name Linde 4-A) is heated at 87 ° C with stirring for 24 hours. After 1 hour of stirring, the product begins to precipitate in the reaction mixture. At the end of 24 hours, the product is separated by filtering the hot reaction mixture, dried, and 2.56 g (effluent 76%) of product is obtained . Elementary analysis of the product. Calculated,%: C 43.68; H 3.91; N13.58. Found,%: C 43.5; H 4.03; Wl3.29. The NMR spectrum confirms the identity of the product.
    Example 37. Preparation of SC) eniptiomep-7- - (2-thienip) -acetamido-3-cefam-4-carboxylic acid 1.2 ". dichloroethane.
    2.0 g (5 mmop) (2-thienip) -acetamido-cefaposporanoic acid and 0.75 ml (7.5 mmol) of benzenthiope are added to 25 MP of 1,2-dichloroethane. The reaction mixture is heated by reverse distillation overnight; Oncological chromatography is not noKaaaTta of the presence of starting iefaposporanic acid. The solvent is distilled off on a rotary evaporator and 25 ml of ethanol is added to the residue and heating is carried out to partially transfer the residue to the solution. A further 25 ml of ethanol are added to the dp transfer of the residue to the solution and heated. The resulting solution is filtered through cotton wool, treated with 2 g of activated carbon, stirred for 5 minutes and filtered through a filter. The solvent is distilled off.
    on a rotary evaporator. NMR analysis of the residue indicates the presence of a certain amount of the starting thiol ,.
    The residue is suspended in 25 ml of isopropyl acetate, filtered and cooled overnight. The filtrate is then diluted with 25 MP of ethyl acetate and washed with 25 ml of dilute sodium 6nKap6oHata aqueous solution to remove thiop. The ethyl acetate layer is added to 25 ml of water, the pH is adjusted from 8.5 to 1.4 with sulfuric acid. The ethyl acetate layer is then dried over magnesium sulphate, filtered / evaporated and evaporated to a foam on a rotary and single phase. 0.92 g are obtained (yield 19.4%).
    NMR (DM80-dv): S 3.58 (t2.2CH), 3.75 (S2. -CHj CONH-), 4.12
    (q.S, 3-cHii -, 3-13 Hz), 5.08 (a,
    1.Sv-H, Hz), 5.66 (tyl, Cr, -H, 0 5 Hz, Hz), 7.15 (-t, 8, thiophenic H and phenyl H) and 9.1Q (1, - SN COMH-, 3 9 Hz).
    Example 38. Preparation of 3-Wb-methcp-1, 3,4-thiadiazol-2-and l) -tyrmethyl-7- (2n}) enyl) acetamido 3-3-cephem-4-carboxylic acid in 1,2-dichloroethane .
    1.95 g (5 mmol) of 7- (2-phenyl) -acetamido-cephalosporanic acid and 0.99 g (7.5 mmop) of 5-metip-1,3,4-thiadiazol-2-thiol in 25 ml 1 , 2-dichloroethane is heated by reverse distillation for 16 hours. Thereafter, thin layer chromatography shows traces of phalosporanic acid. During the reaction, the product crystallizes. The reaction mixture is cooled before and filtered.
    the product is washed with cold 1, chloroethane and dried in vacuum. 1.82 g (yield 78.8%) of product are obtained with a mp. 171-2 C.
    NMR (DM50-Zb): 8 2.7O (S3, -CF1 thiadiazolite), 3.58 (S2, -CH CONH-), 3.7O (broad, S 2,2-CHi), 4.4O (, 3-CHg SJ ii3 Hz), 5.12 (U. Cg-H, 3 5 Hz). 5.72 (fj, 1, C7-H, 3 - 5 Hz, 3 9 Hz), 7.28 (S5, phenyl H) and 9.08 (d 1, -CHj, CO "H-:) 9 Hz ).
    Example 39. Preparation of 3-methy) thiomethi of l-7- (2- (2-thienyl) -acetamido-3-depam ... 4-carbonic acid 6 methiphenchporide.
    24 g (60 mmol) (2-thienip) -acetamido-cephalosporanic acid,. 7.0 ml of methanethiol and 6OO mp of methylene chloride are stirred and heated in a bomb for 18 hours at 84-86 C. Then the reaction mixture is cooled to room temperature. A small amount of insoluble material is filtered and the filtrate is evaporated. The residue is washed with ethyl acetate and filtered. The filtrate is separated by about 15 ml of water and stirred, 1N is added dropwise. sodium hydroxide solution to pH 5.5. The aqueous phase is separated and evaporated to a volume of about 75 ml, then diluted To 700 ml with water, glacial acetic acid is added to pH 3.8. An amorphous precipitate falls, the mixture is stirred for 3 hours in an ice bath, then kept in a refrigerator overnight. Then the solid is filtered; the filtrate is layered with 10O ml of ethyladetate and the pH is adjusted to 2.0 with concentrated hydrochloric acid. The organic phase is separated and extracted with 100 mp of ethyl acetate, then 15O mp of ethyl acetate. The combined organic phases are dried over magnesium sulphate, then the solvent is distilled off and a golden foam is obtained. It is dissolved in 5O mp of ethyladetate, seeded with the desired product and kept in the refrigerator overnight. The crystals formed, separated by filtration, washed with cold isopropyl acetate and dried in vacuo at. 3.2 g are obtained (yield 14%).
    The NMR spectrum confirms the identity of the product: (9 2.0 (-53, 3; -CH2, $ CH3 3.74 (, 2-CH and -CH CON-H.  5.14 (, 1, Sb-N, ag5 Gp), 6.64 (, 1, C7-N, L 5-Hz ,;) - 9 Ha), 7.15 {-t, 3, thiophenic H) and 9.12 (d 1, -CH, CX) fVH3 9 Hz).  Example O.  Preparation of 7- (2-formyloxy-2-phenip) -acetamido-3- (1-metip-1H-tetrazop-5-yl) sodium salt; -3- efem-4-carboxylic acid in benzope, 2.17 g (4.65 mmol) of 7-2-formyloxy-2-phenyl) acetamido-cefaposporacic acid and 0.87 g (7.5 mmol) of 1- Methyl-1H-tetra-el-5-thiopa in 25 ml of benzene is heated by reverse distillation for 12 hours (about 8 ° C).  During - the reaction on the glass, the flask forms with a layer of soft paste-like substance.  When cooled, this precipitate solidified to a glass-like substance. The thin-layer chromatograph1 showed that the product contained in the solution was dissolved, and the product itself was a glass-like precipitate containing some amount of deformed product. The reaction mixture was filled with acetone and evaporated to a pei, which was dissolved in 35 ml of dry acetone and treated with a MP of a solution of 1.25 g of sodium 2-ethane hexanate (7.5 mmop) in acetone.  The product is in the form of sodium salt.  After 1 h, the product is filtered, washed with 2 O of acetone and dried.  1.38 g (yield 58%) of the product are obtained.  Its identity is confirmed thinly: by layer chromatography and NMR.  NMR (): ij 3.48 (% 2-.  2-CHi J-18 Hz).  4, OO (S3, --CHi tetrazolum), 4.1O (nr, 2.3-CHi S), 5.05 (d, l, C5-H, 3-5 Hz), 5.7O (and 1 , Ct-H, Hz).  6.24 {5.1.  -CHCONH-), (tl, 5, phenyl H) and 8.33 (Si.  -Q Example 41.  Preparation of 7- (2-formyloxy-2-phenyl) -acetamido-3- (1-metip-1H-tetrazol-1-ip) -thiome ti-3-cephem-4-carboxylic acid in carbon tetrachloride.  2.17 g I, 65 mmol) 7- (2-formipoxy-2C) enip) -acetamido | - cefaposporanic acid and 0.87 g (7.5 mmop) of 1-methyl-1H-tetrazole-5-thiop in 25 mp of four-carbon carbon are heated by reverse distillation (about) for 12 hours.  Then the reaction mixture is cooled to room temperature and the upper layer is decanted from the solidified semi-solid.  25 mp of 1,2-yichporethan is added to the solid residue with heating. .  The product crystallizes, the mixture is cooled to room temperature and stirred for 1 h. Then the product is separated by filtration, washed with 110 MP 1: 2. | dulsoretan and su9 628 shat in vacuum overnight at 45 C.  : 1.54 g of white crystals are obtained (yield 65%).  The identity of the product is confirmed by NMR analysis and thin layer chromatography, which showed the presence of traces of the deformed product.  The NMR anapiz is identical to the analysis for the product from Example 16.  Example 42  Preparation of 3-methyl 1, 2,4-oxadiazop-5-thiol.  DL g (0.4 mol) of acetamidoxime, 100 ml (1.66 mol) of carbon disulfide and 56 MP (0.4 mol) of triethylamine are mixed and stirred in 1 liter of pyridine.  A stream of nitrogen is passed through the carbon disulfide solution, which is then directed through the reaction mixture.  The mixture is heated in an oil bath to 70 ° C for 3 days, then evaporated to a masp, to which is then added ethyl acetate and a saturated aqueous solution of sodium bicarbonate.  The pools were separated and the organic pool was again washed with a saturated aqueous solution of sodium bicarbonate.  The combined bicarbonate washes were extracted with ethyl acetate and the ethyl acetate washes were discarded.  Water faea is stratified over. press ethyl acetate OHPA. they are waiting in an ice bath.  The pH is adjusted to 2. 5 with 20% hydrochloric acid, then sodium chloride and saturation of the solution are added.  The solution is then extracted with ethyl acetate, washed with a saturated aqueous solution of sodium chlorine, and dried with anhydrous magnesium sulfate.  Then the solution is filtered and evaporated to half the original volume.  An equal volume of carbon tetrachloride is added and evaporation is continued until the product crystallizes.  Get 24. 8 g (yield 52%), Example 43.  Preparation of 3- (3-methyp-1, 2,4-oxadiazol-5-yl) -thiometis-7- (2-thienyl) -acetamido | -3-cephem-4-carboxylic acid in 1.2 dichloroethane.  ido mg (o, 25 mmol) (2-thienium l) -ad tamido J - (carbamic loximet L) -Z-cephem-4-carboxylic acid are suspended in 25 ml 1. 2-dichloroethane when moving and 35 mg (0. 3 mmol) 3-methyl-1,2,4-oxadiazole-5thiol.  The reaction mixture is heated in an oil bath at 11 ° C to distill off 5 MP of the solvent, including traces of water.  Then the temperature of the oil bath is reduced to 90-95 ° C and the reaction mixture is maintained at this temperature for 19 h, then cooled to room temperature.  The insolubles are filtered and washed with 1,2-dichloroethane and diethyl ether.  A thin layer chromatograph showed that it was an unreacted starting material with traces of product.  The filtrate was dried and the remaining oil was partitioned between aqueous sodium bicarbonate and ethyl acetate.  The aqueous solution is exfoliated with fresh ethyl acetate, oHrped in an ice bath and the pH adjusted to 2.5 with 2% hydrochloric acid.  The organic layer is removed, the aqueous solution is extracted with fresh ethyl acetate, the combined ethyl acetate fractions are washed with a saturated aqueous solution of sodium chloride, dried with magnesium sulfate 4%, and evaporated to an oil.  Crystallization from hexane-diethyl ether (1: 1).  gives 13 mg of product (yield 11.5%).  The identity of the product is confirmed by NMR and 1 K-analyzes, which are identical to the analyzes of the compound of Example 32.  Example 44  Preparation of 3-f (l-methi l-1 H-tetrazo L-5-I l) -tyometry l-7 - 2- (tert-butoxycarbonyl-2. phenyl).  - acetamido -Z-cephem-4-carboxylic acid in nitromethane.  49O mg (1 mmol) 7- (2-tert utoxycarbonyl-2. nor l) -acetamido} -cephalosporanic acid and 145 mg (1.25 mmol) of 1-methi-1 H-tetrazo of 11-5-thiol in 15 MP of dry nitromethane are heated at 85-9 ° C for 8 h in nitrogen atmosphere.  Thin-layer chromatography showed the presence of a product, an excess of thiopic reagent and a decarboxylated product, and the absence of the initial poporanic acid cep.  The nitromethane is distilled off, the remaining orange foam is dissolved in 10 ml of a saturated aqueous solution of sodium bicarbonate, then 20 ml of water is added and the mixture is washed successively with ethyl acetate until the washes are clear.  The ethyl acetate washes were combined, 2 O ml of water was added, the mixture was cooled to and the pH was adjusted to 2.2 with 20% hydrochloric acid.  The slurries are separated, the aqueous layer is washed with etipapetat.  These elution solutions were combined, washed with saturated aqueous sodium chloride solution, dried with sulphate, magnesium, fcprucc and evaporated to a brown foam.  455 mg (yield 83%) of the product are obtained.  They are derived from thin layer thin layer chromatography, showing the 6th product, traces of thiol, and decay of the decarboxylated product.  455 mg of product (O, 833 mmol) are dissolved in 7 ml of ethyl acetate and 0.833 mmol of lithium acetate is added dropwise with stirring.  A brown precipitate is obtained, t. e.  lithium salt.  It is separated by filtration, washed with ethyl acetate and dried overnight in vacuo at room temperature.  368 mg (yield 80%) of the product are affected, the identity of which is confirmed by NMR, IR and UV analyzes, thin layer chromatography, bioautogram and elemental analysis.  Thin layer chromatography showed traces of decarboxylated substance.  NMR (,): 5i, 4 (L9, -co-tert-CsNe), 3.6 (. S2, 2-CHj), 3.85 (S3, t trazopny CH), 4.3 (5.2, 3-CH2S-) 4.44 and 4.45 (2 1, CH-), 4.9 ( S1D, 3 6 Hz.  Sv-N) 5.8 (s.  , one, .   Hz, C7-H), 7.35 (S, 5): 8.2 and 7.8 (2 a, 1 3-9 Hz, -СРИН-) and (Ь 1, -СООH).  Example 45  Preparation of 3- (1-metip-1H-tetrazol-5-ip) -thiometry L -7- - N- (1,3-dimetudureido) -carbonyl-2-pheny LG1SCHI-3-cephem-4-carboxylic acid in nitromethane.  13O mg (0.25 mmop) (1. 3-dimethyl pureido-carbonyl l-2 pheny lg tshtsipamido-cephalosporanic acid is suspended in 5 ml of nitromethane and 43.5 mg (0.375 mmol) of 1-methyl-1H-tetrazole-5-thiol is added.  The reaction mixture is heated under nitrogen at 85 ° C for 12 hours.  then keep at room temperature for days.  Then the reaction mixture is filtered and the precipitate is washed small. the amount of nitromethane and dried in vacuo at.  83 mg (yield 58%) of product are obtained. The identity of the product is confirmed by NMR IR and UV spectra, by analysis and thin layer chromatography and bioautogram.  NMR (DMaO-3b): 8 2.65 (i 3.3 -i 4 Hz, -SSNR), ЗД5 (. S3, COMCH CO-), 3.6 (. $ 2, 2-SNg), 3. 9 ($.  3, tetrazopny CH,), 4.3 (S2.3-CHi 5, 0 (3.1, D 5 Hz, Sat-H), 5.5 (a 1.3 7 Hz, SISO) 5.7 (, C7-H), 5.8 (f 1, -CONHCHi,), 7.4 (S. 5), 9.3 (, 3 “-8 Hz.  CHCONH-) and 10 (a 1,.  Hz  cn-con / Example 46.  Preparation of 3 - | l-methy7-1H-tetrazo-5-5-yl) -thiomethyl-7-.  - (2 tienip) acetamido-3-cephem-1 -carboxylic acid in aetonitrippe with the addition of tetrybutilammonium iodide.  2.0 g (5 mmol) of 7- (2-tienip) -acetamido-cefaposporanic acid 1.2 g (10 mmol) of 1-metip-1H-tetra-.  3OI5-5-thiol and 0.2 g of tetrabutylammonium iodide are mixed with 25 ml of dry acetonitrile, heated by reverse distillation for 8 hours.  The reaction mixture is then cooled to room temperature and the solvent is distilled off on a rotary evaporator.  The residue is treated with a hot mixture of 25 ml of isopropyl acetate and 5 ml of acetonitrile, filtered and allowed to cool slowly.  The product falls out in the form of light cream crystals, they are filtered, washed with isopropyl adatate and dried.  1.3 g (product yield 57.5%) are obtained.  NMR analysis of the product is identical to the product of example 5.  Example 47  Getting 3 1. -metip-1H-tetrazol-5-yl) -thiomethyl -7.  - 2- (2-thienyl) -acetamido-3-cephem-4carboxylic acid in 1,2-dichloroethane with the addition of tetrabutypammonium iodira.  Repeat the reaction of Example 52,. but 1,2-dichloroethane was used as a solvent. 2 ml of dicyclohexipamine was added and the product was obtained in the form of the dicyclohexylamine salt in the amount of 1.55 g (yield 48.5%).  NMR spectrum is identical to the product of example 1. Example 48.  Getting 3- (fe iptiometip) -7- 2- (2-tneyl-acetamide-to} -3-cephem 4-carboxylic acid in 1,2-dichloroethane with the addition of 1-methyl-5- (metipti) -1H-tetrazop .  2.0 g (5 mmop) (2-thionip) -detamido-cephalosporanic acid, 0.75 ml (7.5 mmop) of benzthiazole and 0.65 g of 1-methyl-5- (methylthio) -1H-tetrazole are mixed in 25 mp of 1,2-dichloroethane and heated with reverse peregbnkoy.  The progress of the reaction is followed by fine solder chromatography; it ends after 14 h.  The solvent is distilled off on a rotary evaporator, the residue is re-extracted with diethyl ether.  After careful removal of the solvent, 1.66 g of a brown substance remained (yield 74%).  IR and NMR analyzes are identical to the products from the previous examples.  Example 49  Step 3-1 (1-metip-1H-tetraa) P-5-ip | -thiomethyl -7-2- (2-tienip) -aaamido-β-cefem-4 carboxylic acid in isopropane.  2.0 g (5 mmol) of 7-G2- (2-thienyl). I.   α-acetamido-cephinum of losporopic acid, w 0.87 g (7.5 mmop) of 1-metip-1H-tetrazol-5-thiol in 25 ml of isopropanol are charged to a flask equipped with a reflux condenser with an anhydrous calcium sulfate-containing tube.  The flask is immersed in an oil bath at 84-85 C.  The progress of the reaction is followed by thin layer chromatography.  After 40 hours at 8 2-83 ° С, only half of cefaposporanic acid reacted.  Example 5O.  Preparation of 3- (2-oxazolylthiomethyl) -7-L2- (H-tetrapazop-1-ip) -acetamido 3 -3-cephem-4-carboxylic acid in nitromethane.  A suspension of 0.38 g (1 mmol) of 7- 2- (1H-1-tetrazol-1-yl) acetamido-cephalosporanic acid and 0.11 g (1.1 mCup) of 2-oxazoptiopa in 5 mp of nitromethane in a flask are immersed in oil a bath at, 90-91 ° C. In a flask, an atmosphere of dry nitrogen is maintained.  After 20 minutes, all reagents have dissolved, and after 35 minutes, the product begins to cristipize.  After 6 h, the reaction mixture is cooled to room temperature and the product is filtered, washed with 7 ml of nitromethane.  dried in air for 3 hours at a temperature of 0.36 g (yield of Kristapp is an off-white color, 85.7%) of the product with m.  square  196 ° C (razp. ).  NMR analysis promoted the presence of 7% of the product and 30% of the original cefapsporic acid.  The product is crystallized from 5 ml DM. §0ds and 1O ml of water, separated by filtration, washed with 5 ml of a 2: 1 mixture of water-DM-50-fls 1, dried in air, then under vacuum for 6 hours, and dried, 26 g of product.  NMR analysis showed that the product contained 87% of the desired product and 13% of the original cephalosporanic acid, Recrystallization was repeated 3 MP DM $ 0-8 B and 6 mp of water, stirred for 1 h, and 0.21 g of product was obtained.  The NMR anapis of the product showed that the content of the initial cefaposporanic acid was reduced by about 5%, and confirmed the identity of the chain product.  NMR (DM50-Av): 8 3.75 (S2, 2-CHi.  , 34 (2, 3-CHi.  S3. 14 Hz), 5.16 (d, bn, 3 5 Hz), 5.76 (CLI, C -, - H, 3-5 Hz.   Hz).  5.44 (8.2, H-). 7.28 (8.1, oxazopyrl Cch-H), 8.14 (8.1, provosnop1. 1st Cs-H), 9.37 (5.1, tetrazopy H) and 9.53 (d, l, -CONH-, 3-.  Hz).  Example 51  Preparation of 3- (2-oxazoliptiometyp) -7-G (2-formipoxy-2-phenyl) -acetamido-3-cephem-4-carboxylic acid in 1,2-dihydropane.  A solution of 0.52 g (1 mmop) of 7-K2-formipoxy-2-phenyl) -acetamido D-cephalosporanic acid (methypeichloride solvate) and 0.12 g (1.1 mmol) of 2oxazolthiope in 2O ml of 1,2-dichloroethane are heated back-distilled for about 16 hours, then cooled to room temperature.  Thin layer chromatography showed conversion to product.  The reaction mixture is evaporated on a rotary evaporator to a volume of 10 ml, and after standing the mixture some gelatin-like crystals precipitate.  They are filtered, washed with 1,2 dichloroethane, and dried.  Get 0.12 g of solid gray matter.  Careful removal of the solvent from the filtrate gives another 0.45 g of light yellow foam.  It is triturated with 25 ml of diethyl ether, filtered, washed with diethyl ether and dried.  Obtain 0.21 g of light yellow powder.  The identity of the product is confirmed by NMR analysis: S 3.56 {mn2, 2-CHi. ), four. 24 (3. 2, 3-SNg.  S, Hz), 5, OO (A 1- G. -N    5 Hz, 5.70 (s ;. , CI-H.  - -HHz), 6.14 (. 5.1 CH-.  7 2 5 (& 1, oxazole), 7.45 (-p1.5, phenyl H), 8.12 (5.1, oxazopny CS-H), 8.35 (S, l-CHO) and 9, 4O (d, l -CONH-0 9 Hz).  Example 52  Preparation of 3- (4-phenyl-2-thiazolylthiomethyl) (2-thienyl) -acetamido-3-cephem-4-carboxylic acid in acetonitrile.  A mixture of 2.0 g (5 mmol) (2-ti of Ni) -aietamido-cephalosporanic acid and 1.44 (7.5 mmol) of 4-fe1shl-2-thiazolthiol in 35 ml of acetonitrile is heated by reverse distillation for 16 h at protection from air moisture with an anhydrous calcium sulfate drying tube.  Thin layer chromatography showed a clear conversion to a new point.  After cooling the reaction mixture to room temperature and stirring for 2 hours, the product crystallizes, it is filtered, washed with acetone. 2.55 g of tonitrile are obtained and dried (yield 85.6%) of product with m. square  180 C (decomp. ).  DFID showed product identity.  Example 53  Preparation of 3 -11 5-methyl-1, 3,4-thiadiazol-2-yl) -thiomethyl-7-G2- (1H-tetrazol-1-yl) -acetamido} h 9,634 -Z-cephem-4- carboxylic acid in nitromethane.  1.92 g (5 mmol) (1H-tetrazol-1-yl) -acetamido-cefaposporanic acid and 0.79 g (6 mmol) 5-methyl-1, 3,4-thiadiazol-2-thiol are added to 25 ml of alumina-purified nitromethane and the reaction mixture is heated with an oil bath with stirring for 4 hours.  Thin-layer chromatography showed complete conversion and traces (about 2%) of the initial cephalosporanic acid.  The reaction mixture is cooled to room temperature lyfibi, filtered, washed with nitromethan, dried in vacuo, and 2.11 g (discharged 92.5%) of product are obtained with m. square  183.5 s (decomp. ).  NMR confirmed the identity of the product.  PR is p 54  Preparation of 3 -R5 -methyl l-1,3,4-thiadiazol-2-y and l) -tyometype -7- (1H-tetrazol-1-yl) -acetam- to-3-cephem-4-carboxylic acid in propionitrile.  1.92 g (5 mmol) of (1H-tetrazop-1-yl) acetamido-chefalosporanic acid and 0.99 g (7.5 mmol) of 5-methyl-1, 3,4-thiadiazol-2-thiol are added to 25 ml of propionitryl (treated with neutral alumina) and heated with reverse distillation (97 ° C) with stirring for 9 hours.  Thin layer chromatography showed only traces of starting cefaposporanic acid.  Then the reaction mixture is cooled to room temperature, ({it is diluted, washed with propionitrile and dried in vacuum.  Obtain 2.04 g (yield 89.5%) of the product with so square  186.5 ° C (decomp. ).  NMR confirms the identity of the product.  Example 55  Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7- - | 2-formyloxy-2-phenyl) -acetamido-3-cephem-4-carboxylic acid in 1,2-dichloroethane.  13.62 g (0.05 mol) of 7-ACA (7-aminocephalosporanic acid) are suspended in 100 ml of 1,2-dichloroethane and 26.25 g (0.2 mmol) of trimetipsyl-acetamide are added.  The reaction mixture is heated at 4 ° C, while the solids dissolve to form a cloudy solution, which is cooled to 20 ° C.  To a drop of 20 quin is added dropwise at a temperature rise up to 10.92 g (0.55 mol) of a solution of 2n | yrmyloxy-2. nilieti71 chloride in 25 ml of 1,2-dichloroethane.  Then the reaction mixture was stirred for 2 hours, added with 1OO ml of 1,2-dichloroethane and the reaction mixture was washed three times with water in 100 ml portions.  The aqueous washes were combined and extracted in portions of 50 ml of 1,2-dichloroethane, which were again pressed into 4O mp of water.  The layers of 1,2-dichloroethane are combined, mixed for 2 minutes with 2.0 g of activated carbon (trademark Darko-C-bO) and filtered through diatomaceous carbon (trade mark Hiflo).  The total volume of the solution is 375 ml. It contains the desired 7 (2-formidoxy-2-phenyl) -acetamido-cefaposporanic acid.  This solution is evaporated at 30 ° C to 336 g - 25 O ml of 1,2-ichloroethane and 22 g of 7- (2 ormyloxy-2-phenyl) -acetamide-cephalosporanic acid.  6-, 39 g (55 mmol) of 1-methyl-1H-hetrazol-5-thiopa in 25O ml of 1,2-dichloro ethane are added and the reaction mixture is heated by refluxing for 12 hours.  After cooling down from previous washes), the mixture was anisotropically blended in the refrigerator and the head returned to the flask, and a trap was used to trap water.  Thin layer chromatography after 12 h showed an almost normal reaction.  The reaction mixture is cooled to room temperature, seeded with a seed to precipitate the product, i.e., 3- (1-methyl-1H-tetrazol-5-yl) -thiometig1 | -7- (2 "t-I.  β-formyloxy-2-phenyl) -acetamido-3-cephem-4-carboxylic acid.  After 2 hours, the product is filtered, washed with 6.3 ml of 1,2-dichloroethane and 13.90 g (yield: 56.7%) of 7-ACA are obtained.  Thin layer chromatography of the product was clear.  NMR confirmed the identity of the product is identical with the NMR of the product from example 16.  Example 56.  Preparation of 3 - {(1-methyl-1H-tetrazop-5-yl) -thiomethyl -7- - (2-h) ormyloxy-2-phenyl) -acetamido | - -Z-cephem-4-carboxylic acid in 1,2dichloroethane.  2.33 g (5 mmol) of 7- (2-formyloxy-2-fene or p) -acetamido-ceph of sposporic acid and 0.64 g (5.5 mmol) of 1-metip-. 1H-tetrazole-5-thiopa is added to 25 ml of 1,2-dichloroethane and the mixture is heated by reverse distillation for 12 hours.  The reaction mixture is cooled to room temperature, then reheated to reflux temperature and 10 ml of solvent are distilled off.  Then, at a temperature of inverse distillation, 636 W are added () by calp m 1O mp of 4-carbon.  The mixture is allowed to cool to room temperature and stirred for 1 hour.  The product is separated by filtration, washed with 14 ml of a 40% aqueous solution of carbon tetrachloride in 1,2-dichloroethane and dried in vacuum at 5 ° C.  . 2.12 g (yield: 86.5%) of a light-colored solid are obtained.  NMR analysis is identical with the NMR analysis of the product from example 16. / Example 57.  Preparation of 3- (3-nzyloxycarbonylaminomethyl-1, 2,4-triazol-5-yl) -thiomethyl1-7- (2-thienip) -acetamide6} -3-cephem-4-carboxylic acid in nitromethane.  2 g (5 mmol) (2-thienyl) -acetamido-cephalosporanic acid and g (7.6 mmol) - (benzyloxycarbonylaminomethyl) -1,2,4-triazole-5-thiol in 35 ml of nitromethane are heated at 8 ° -90 ° C for 6 hours with stirring.  The reaction mixture is cooled and filtered to isolate the project.  It is recrystallized twice from aqueous acetone and 1.2 g of cream crystals are obtained, c. square  174-178 C (decomp. ), (yield 40%).  Calculated,%: C 49.99; H 4.03; N13.99; 81b, 01.  C2. sH2 Nfe §g Found,%: C 50.2; H 4.03; N13.76; S15.68.  With mr 58.  Getting 3- (1 (-.  .   -ll SiriC I A.  -carboxymethyl-1H-tetrazol-5-yl) -thiomethyl -7- - (2-thienyl) -acetamides) -3 ncefem-4-carboxylic acid in acetonitrile.  I - - - t -1.0 g (2.5 mmol) (2-tienip) - cetamido} -cephalosporanic acid and 0.61 g (3.8 mmol) of 1-carboxymethyl-1 H-tetrazole-5-thiol 75 mp acetonitrile is heated to boiling and 35 MP solvent is distilled off.  Then the reaction mixture is heated under reflux for 13 hours, cooled, 4 ml is ruled and evaporated under reduced pressure.  The residue is dissolved in ethyl acetate, washed with 1 and.  hydrochloric acid and brine, and dried with sodium sulfate.  Hexane is added and the precipitate is precipitated, which is separated and dissolved with ether to give 0.475 g of a brown solid (yield 38%).  The identity of the product is established by comparison with an authentic sample obtained by another method.  An example. 59.  Preparation of 3- (5-methi l-1,3,4-thiadiazo l-2 -l l) -tyometype) -l-l (3-hpor-capsidine -3- efem -4 - carbon ijrtcnoTbi in nitromethane.  Mixable suspension 1.0 g. (2.5 mmop) 7- (3-chloro) -propionamido- “Efaposporanic acid and 0.4 g (3 mmol) of 5-methyl-1,3,4-thiadiaeop; 2 chiopa in 20 ml of nitromethane are heated on a large bath at 95-96 C.  According to thin layer chromatography, the reaction is over in 3 hours.  The reaction mixture is cooled to room temperature, filtered and evaporated in vacuo to give a light red oil, which crystallizes upon standing at room temperature for 2 hours.  It is then triturated with 15 ml of etipacetate, filtered, washed with ethyl acetate and dried.  Obtain 0.64 g (yield 55.2%) of the product.  The identity of the product is confirmed by IR, UV-NMR, titration and microanalysis.  Elementary analysis.  Calculated,%: C 41.51; H 4.14; N12.10; & 20.78: se 7.6b.   Sj Found,%: C 11.7; H 4.23; N11.84; S20.51; From 7.88.  Example 6O.  Preparation of 3- (1-benzip-1H-1, 2,3-triazole-5-ip) -thiometype -7-2- (2-thienyl) -acetamido-3-cephem-4-carboxylic acid in 1,2- dihpore ethane.  20 O mg (0.5 mmol) (2-ni-l) -acetamido 3-ceph of a new acidic acid and 140 mg (0.7 mmol) 1-benzyl-1H -1,2,3-triazole-5- the thiol is mixed in 15 ml of 1,2-dichloroethane and heated in for 21 hours at 65-7 ° C.  The solvent is then distilled off under reduced pressure, 25 ml of a saturated solution of sodium bicarbonate in water are added and the mixture is extracted with two portions of these acetate.  Fresh ethyl acetate was added to the remaining aqueous solution, the solution was cooled in an ice bath and the pH was adjusted to 2.5 with 2%.  solution of NS.  Sour product. extracted with two portions of ethyl acetate, and the combined ethyl acetate washes were washed with a saturated aqueous solution of sodium chloride, dried with anhydrous magnesium sulfate.  The magnesium sulfate is filtered and the etipacetate is distilled off in vacuo.  76 mg of product is obtained, which according to the thin layer.  chromatography was a mixture of the starting material and the product as compared with  authentic sample - the product and the original substance, Example 61.  Preparation of 3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7-2-(4-ethyl-2,3-dioxo-1-piperazinylkyrbonylamino-2-phenyl) -acetamid5-3-cephem-4 -carboxylic acid in nitromethane.   0.3 g (0.5 mmol) hydrate of (4- "thyl-2, 3-dioxopiperazinylcarbonylamino-2-phenyl) -acetamido | - cephalosporanic acid and 0.0725 g (0.625 mmol).  1-methyl-1H-tetrazole-5-thiop is added to 6 ml of nither hemethane, previously dried with alumina, and the mixture is heated at 85 ° C under nitrogen for 12 hours.  The nitromethane is then distilled off: the remaining brown foam is dissolved in sodium bicarbonate solution, in water and washed twice with ethyl acetate. Fresh ethyl acetate is added, the mixture is cooled to O С and adjusted to 2.3.  The layers are separated, the aqueous solution is washed with ethyl acetate.  The ethyl acetate washes were combined, washed with a saturated aqueous solution of sodium chloride, dried with anhydrous magnesium sulfate, and filtered. rut and evaporate.  Get 13O mg light yellow powder (40% of theory).  The identity of the product is confirmed by NMR: S 1,2 (t, 3, -H-CHj CHj,: 5g7 Hz), 3.65 (m, 6, N, and piperazinyl N), 4.0 (S, 3, -tetrazol CHj), 4.4 (S, 2,), 5.1 (3.1, Sat-H, 3 6 Hz).  5.8 (hell, C7-H, 3-8 Hz), 6.0 (d, l ,, 3 6 Hz), 7.41.5.  . .   K-phenyl H).  8.4 (3-, l. . r-SNSO N H-,: i - 8 Hz) and 10.0 (a, 1, -снсо1 "n-. 7 -. one. . H 6.  Example 62  Preparation of 3- (1-carboxymethyl L-1H-tetrazo-5-41 L) -type -7- - (4-ethyl-2,3-dioxo-1-pi-pyrazinylkarbonylamino-2-phenyl) -acetamido-j Snf-4-carboxylic acid in 1,2-dichloroethane.   O, 3 g (0.5 mmol) of 7 -2- (4 thyl-2, 3-dioxypiperazinylcarbonylamino-2-fesh1l) -acetamido} -cephalosporanic acid hydrate is dissolved in 45 ml of 1,2-dichpo1 ethane.  pre-dried with alumina, and the solution is heated to 95 ° C for anisotropic distillation of water.  After 40 ml of the solvent have been collected, 10 ml of nitromethane and 0.16 g (1 mmop) of 1-carboxymethyl-1H-tetrazole-5-thiol are added and the reaction mixture is kept up and drinking; for 12 hours under nitrogen.  Then, the α-reaction mixture is filtered and evaporated, a smop is obtained, to which ethyl acetate and a saturated aqueous solution of sodium bicarbonate are added.  The mixture is washed twice with ethyl acetate, fresh ethipacetate is added, the mixture is cooled to and the pH is added to 2.3 using 20% - n HC.  The layers were separated, the aqueous layer was washed with ethyl acetate, the ethyl acetate layers were combined and washed with a saturated solution of HC2, dried with anhydrous magnesium sulfate, filtered, evaporated and dried at room temperature.  123 mg of product are obtained, the identity of which is confirmed by NMR: 1.2 (t3, CH2. CHJ, D -7 Hz), 3.0 (tp | 4, N, and piperazinyl 5-H), 4.1 (tp, 2, piperazinyl 4-H) 4.4 (& 2, 3-CHg.  -), 5.1 {(3.1, CS-H, 3-5 Hz), 5.3 (S 2, tetrazole 1 - CH2. COOH): 5.75 (6.1, 3,6 Hz), 7.4 (mn, 5, fenip. 5.9 (s, 3 Hz).  ny) and 9.9 {1, 63.  Preparation of 3- (1.5 Example -dihydro-4-methyl-6-hydroxy-5-oxo, 2,4-triazin-3-yl) -thiomethyl -7-15- (4-egil -2,3-dioxo -1-pipa razini pkaryo pamino 2-phenyl) -acetamido-3-cephem-4-carboxylic acid in nitromethane.  0.3 g (0.5 mmol) (4-ethyl-2, 3-dioxo-1-piperazine lcarbonyl and foreign 2-phenyl) -acetamido-cefaposporanic acid and 0.111 g (0.625 mmol) 4,5-dihydro The 4-methy-6-hydroxy-5-oxo-1, 2,4-triazine-3-thiol is dissolved in 10 ml of nitromethane under nitrogen at room temperature and the reaction mixture is heated at 85 ° C for 12 hours.  A brown gummy precipitate forms, which is discarded.  The solvent slowly distills off a yellow precipitate.  The residue is cooled, the fit is triturated and washed with diethyl ether.  Two batches of white-solid solid with identical thin layer chromatography are obtained.  The total output is 80 m (24%).  The identity of the product is confirmed by NMR: b 1.1 (t3, DHjC J6 Hz), 3.3 (Dtriazine CH), 3.65 (mn4, -N-CH CH and piperazinyl 5-H), 4.0 (t2, piperazinipny . 6-H).  4.6 (5.2, 3-CH2. -3)  5.1 (d, l.  & 640 Cg-H, Hz), 5.85 (tp, 2 / i), 7.45 (t, 5, phenyl H), 9.5 (dl, i, -c-nsoon, 3 8 Hz) and 10 , o (a-, 1, VcH- 3-) IfH Example 64.  Preparation of 3- | j (5-methylthio-1, 3,4-thiadiazol-2-yl) -thiomethyl (1H-tetrazop-1-yl) -acetamido T-3-cephem. -4-carboxylic acid in nitromethane.  15, Og (39.2 mmol) 7- / 2- (1H-tetraacids and 6.43 g (39.2 mmol) of 5-methyl thio-1,3,4-thiadiazop-2-thiol are suspended in 50O ml of nitromethane, passed through a column with neutral alumina.  The mixture is heated at 95 ° C and maintained at this temperature for 6 hours, then cooled overnight, filtered, washed with 25 O ml of nitromethane and dried for 4 hours at.  18.08 g (yield 94.9%) of product are obtained.  150 ml of water and 4 ml of acetic acid are added to the product, the pH is adjusted to 6.3 with 1N.  sodium hydroxide solution (flow rate 107 ml) and the mixture is stirred for 1 h.  Then a solution of 257 ml of 6O% pactate and 60 MP of ethanol is added and the mixture is allowed to stand for 45 minutes.  Then it is stirred for 45 minutes, filtered, washed three times with ethanol, dried, and 18.1 mg of product is obtained, which is again suspended for 3 hours, then suspended.  rinsed, washed with ethanol and dried.  14.85 g of product are obtained, the identity of which is confirmed by pressure chromatography.  Examples 65-72.  Preparation of 3- (5-methyl-1,3,4-thiadiazol-2-ip) -thiomethyl-7-2- (1H-tetrazol-1-and l) -acetamido-3-cephem-4-carboxylic acid in various solvent x.  (-H-tetrazol-1-yl) -acetamido-cephalosporanic acid is reacted with 5-methyl-1,3,4-thiadiazol-2-thiop in various solvents.  Detailed details of the reaction are given in the table (all other aspects of the reaction are typical of the previous examples), Example 73.  Preparation of 3-1 (1-methyl-1H-tetrazol-5-yl) -thiomethyl-7- (2-hydroxy-2-phenyl) -acetamido -. 3-cef, m4-carboxydate lithium in glacial acetic acid.  0.48 g (1 mmop) of 7-i2-hydroxy-2-phenyl) -acetamndo-cefaposporanic acid and 0.5 g (4.3 mmol) of 1-metip-1H-tetrazole-5-thiopa in 15 ml of ice acidic acid react for 8 hours at 84–86 ° C.  The reaction mixture is then cooled to room temperature and 0.4 g (1.6 mmop) of iodine is added to convert the unreacted thiol to disulfide.  The mixture is stirred at room temperature for 20 minutes, then poured into 100 ml of etipacetate and 5 O ml of water, and the excess iodine is removed by the addition of sodium sulfite.  The layers are separated, the etipacetate copay is washed with two portions of 100 ml of water and in one portion in 50 ml of 20% sodium chloride solution in water, dried with anhydrous sodium sulfate, this is distilled off on a rotary evaporator, the residue is dissolved in 1O ml of methane.  Lithium acetate dihydrate (0.21-2 mmop) was added and the mixture was stirred for 20 minutes at room temperature.  The product is cristapped, separated by filtration, washed with 5 ml of methanol and dried.  0.34 g of white Kristap is obtained (yield 69.4%).  Product identity, confirmed by NMR: 5 3.50 (ABo.   Hz), 3.92 (S-CHj tetrazop).  4.20 S3-CHj S-) 5.04 (dCg-H, a 5 Hz), 5.24 (3, CH 2 H), 5.64 (d, C7-H, 0 5 Hz) and 7.44 (SH).  The NMR spectrum is identical to the spectrum of an authentic sample of a product obtained by water mixed.  Example 74  Preparation of meth21l-1H-tetrazop-5-yl) -thiometype -7-12- (1H-tetrazol-1-yl) acetamide 6T-3-l-cephem-4-carboxylate lithium in acetonitrile.  1.91 g (5 mmol) (1H-tetra.  sol-1-yl) acetamido-cephalosporanic acid and O, 7 g (6 mmol) of 1-methyl-1H-tetrazol-5-thiop in 5O mp acetonitrile are refluxed for 24 hours and cooled to room temperature .  The solvent is distilled on a rotary evaporator to a trench. 10 ml.  40 ml of ethanol and a solution of 0.3 g of lithium hydroxide in Yuml methanol are added.  The product 3- | (1-methyl-1H-tetrazop-5-yl) -thiomethyl-7- | 2-1H-tetrazol-1-yl) and etamido-3-efehem-4-carboxylate, piti, start to crystallize.  After stirring the mixture for 45 minutes at room temperature, the pro- duct is separated, filtered, washed with ethanol and dried under vacuum at.   1.60 g (yield 72%) of product is obtained, the identity of which is confirmed by the NMG-α-spectrum.  Example 75  Preparation of 3-5-methyl-1, 3,4-thiazolol-2-yl) -thiomethen-7- (2-formyloxy-2-4) enyl) -acet-.  amndo-3-cephem-4-carboxylic acid in 1,2-dichloroethane.  4.6 g (8.8 mmol) of 7- (2-formyl-2-phenyl g1) -acetamido-cephalosporanic acid and 1.52 g (11.5 mmol) of 5-methyl-1,3,4-thiadiazole -2-thiol in 5 O ml of 1,2-dichloroethane is refluxed for 12 hours, then cooled to room temperature.  The product falls out in the form of a thick paste.  The mixture was diluted with another 50 ml of 1,2-dichloroethane and stirred for 4 hours at room temperature.  The product is then separated by filtration, washed with 1,2-dichloroethane until clarity of the filtrate and dried in vacuo at 4 ° -45 ° C.  Obtain 2.8 g (yield 63%) of the product, the identity of which was confirmed by the NMR spectrum.  Example 76.  Preparation of 3 (4,5-dihydro-6-hydroxy-4-methyl-oxo-1,2,4-triazin-3. -yl) -thiomethyl -7- (1H-tetrazol-1-yl) -acetamide4 -3-cephem-4-carboxylic acid in acetonitrile.  8.9 g (23.2 mmol) (1H-tetrazol-1-yl) -acetamides 5 -cephalosporanic acid and 4.1 g (25.8 mmol) 4,5-dihydro-6-hydroxy-4-metip-5 -oxo-1, 2 4-triazin-3-thiol in 2OO ml of acetonitrile is refluxed for 23 hours, then cooled to room temperature.  The product that crystallized out during the reaction was separated by filtration, washed with 5 O mp of acetonitride and dried in vacuo at 4 ° -50 ° C.  9.70 g (yield 86.6%) of product are obtained, the identity of which is confirmed by NMR. spectrum.  0.86 Acetonitrip Reverse (dried by distillation).  ka 0.363 Nitrobenzene 85 and 10 0.5 1: 1 mixture of 85 dichloroethane and nitroethane 0.5 Nitroethane90 1.98 Propipencar- 95 carbonate 0.9 9 Ethyl carbonate 95 1.91 2.02 1.00 Acetic acid 85
    权利要求:
    Claims (3)
    [1]
    1.92 O, 79 A mixture of 52.5% 95
    nitromethane and 47.5% 2 nitropropane as sodium salt. F 6r of the invention mimic 1. Method for preparing cephalosporinoic compounds of the general formula 1 "2-Frh 0 y CHggJ 3 where I is hydrogen or methoxy; RI - formamidogitpa, group fori Ri-CHg-C-llH-. . / where is hydrogen, fenip, phenoxy-, til NIL-, tetrazoga-1-yl, cyano-, chlorophenylthio-, phenethiptioyl-tert-butoxycarbonylamino "tipphenyl; or RJ - ipfima of the general formula Bg-CH-C-lTHТ €
    89
    5O min 181 (rap.) 182-183 (decomp.) 177 (paari.) Where is phenyl; R 8 - OXY-, ureido-, fbromi loxipipi tert-butoxycarbonyl radical; or phenyl or hydroxyphenyl; Rj is 4-ethyl-2, 3 Dioxane piperazinylcarbonylamino radical; or R 2 -group of the general Formula Socn-Sn - (; n2) C-C Rde; R is hydrogen or methyl; or Rj is rpvnna of the general formula O K - / -CH-C IN - / I tsh-bz: where R J is hydrogen or hydroxy; R 5 is tert-utoxycarbonyl or dimethyl ureidocarboiyl; or - tert-butoxycarbonylamino or 3-chloropropionamido radical; 459 R. - tetrazop-5-un, unsubstituted or substituted by methyl, benzyl, soup, fonyloxy or carboxymethyl radical, oxadiazol-5 - un, unsubstituted or substituted by methyl. 1,3,4-thiadiazop-2 "yl, unsubstituted or 5- substituted by methyl, phenyl, K-methylacetamide or methylthioradical, triazol-5-yl, unsubstituted or substituted by benzyl or benzyloxycarbonylaminomethyl, 4-phenyl-2-thiazolyl, 2- gshrimidinip, amine dyno, benzoyl, phenyl, methyl, 2-oxvzolyl, 2-benzthiazolip or 4,5-dihydro-6-hydroxy-4-methyl-5-oxo-1, 2,4-triazinip, with the proviso that R - a methoxy group, when C is phenyl or tetrazop-1-yl, by the interaction of the corresponding 3-nigh apcanoyloxymethyl cephaposporin with the corresponding thiol or with thiourea when heated in medium organic solvent, which begins with the simplification of the process technology, the connection of the general formula 1. 2-Hp U) r, 3H20COR O t where f and Rj are the indicated values; R, (j-C-St-alkyl or cyclobutyl, is reacted with a compound of the general formula Ij. Itj-SH. Where Ri is the indicated value, besides the amine dinoradical, if R 6 is amidinyl radical, with thiourea and the process is when the water content of the solution is less than 5 wt.%.
    [2]
    2. The method according to claim 1, characterized in that the heating is carried out to 50-140 C.
    [3]
    3. The method according to claim 2, that is, with the fact that the heating is carried out to 70-120 C. 4, The method according to PP. 1-3, characterized in that an organic solvent selected from the group comprising a hydrocarbon, alcohol, amide, ether, ketone, carboxylic acid, carboxylic acid ester, hapoid hydrogen, nitrocarbon, nitrip and thioether is used. 5. The method according to claim 4, that is, with the use of an organic solvent selected from the group comprising acetonitrile, 1,2-dichloroethane, methylene chloride ,. propionitrip, nitromethane, nitroethane, acetic acid, isopropyl acetate, butyladethate, methyl isobutyl ketone, fluorobenzene, thiophene, methyl ethyl ketone, 1,1,2-trichloroethane, chloroform, benzene, carbon tetrachloride, isopropanol, nitrobenzene, nitrocarbon, nitrocarbon . Sources of information taken into account in the examination 1. US Patent No. 3278531, El. 260-243, pub. 1966 (prottip).
    类似技术:
    公开号 | 公开日 | 专利标题
    FI67555C|1985-04-10|PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ANALYSIS | -7 - | -2- | -2- | -ACETAMIDO) -3- | -CEF-3-EM-4-CARBOXYLA T
    US4912212A|1990-03-27|Cephem compounds
    SU919596A3|1982-04-07|Process for producing cephalosporin comrounds
    FI73440B|1987-06-30|FOERFARANDE FOER FRAMSTAELLNING AV SOM CEILING MODEL ANVAENDBARA ALKYL- | CARBONYLOXIALKYL-7- / 2- | -2-METOXY- | CE-METH-3-METHOD-3-METHOD -4-carboxylate.
    JPH0684338B2|1994-10-26|Substituted acetic acid derivative
    DK165924B|1993-02-08|METHOD OF ANALOGUE FOR THE PREPARATION OF CEPHALOSPOR COMPOUNDS AND PHARMACEUTICAL LANGUAGE SALTS THEREOF, AND A PRIOR MATERIAL FOR USING THE PROCEDURE
    US4048311A|1977-09-13|7-Acyl-3-|cephalosporins
    FR2552088A1|1985-03-22|NOVEL PROCESSES FOR PREPARING CEPHALOSPORINS
    FI63586B|1983-03-31|PROCEDURE FOR THE FRAMSTATION OF AV 7-BETA- | -3- | -3-CEFEM-4-CARBOXYLSYROR WITH ANTIBACTERIAL NETWORK
    US3907786A|1975-09-23|7-{8 {60 -|acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts
    IE41590B1|1980-02-13|Novel cephalosporin compounds
    CH646963A5|1984-12-28|THIOLOESTERS AND PROCESS FOR THEIR PREPARATION.
    US3946000A|1976-03-23|7-[α-|-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
    US4067880A|1978-01-10|Intermediates for preparing 7-acyl-3-|cephalosporins
    FR2496666A1|1982-06-25|NOVEL CEPHALOSPORINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
    CA1148154A|1983-06-14|Thiols and their preparation
    US4118490A|1978-10-03|7-Acyl-3-|cephalosporins and pharmaceutical compositions containing them
    HU179967B|1983-01-28|Process for preparing 7-acyl-amido-3-thiomethyl-3-cefem-carboxylic acid derivatives
    GB2033390A|1980-05-21|Process for the Preparation of 7-aminothiazolylacetamido- cephalosporanic Acid Derivatives
    US4159373A|1979-06-26|7-Acyl-3-| cephalosporins
    US4371531A|1983-02-01|Cephalosporin compounds
    LU82979A1|1981-03-26|N-SUBSTITUTED THIAZOLYL DERIVATIVES OF CEPHALOSPORINS SUBSTITUTED BY AN OXY-IMINO GROUP
    KR830001278B1|1983-07-01|Process for preparing cephalosporin compound
    FI74975C|1988-04-11|FOERFARANDE FOER FRAMSTAELLING AV NYA 7- - | ACYLAMINO-3- | ACYLAMINO-METHYL-3-KEFEM-4-CARBOXYLRADERIVAT.
    FI72521B|1987-02-27|FOERFARANDE FOER FRAMSTAELLNING AV CEFALOSPORINDERIVAT.
    同族专利:
    公开号 | 公开日
    US4144391A|1979-03-13|
    ZA781258B|1979-10-31|
    BE864459A|1978-09-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    GB1012943A|1961-05-16|1965-12-15|Glaxo Lab Ltd|Improvements in or relating to antibiotics|
    GB1241657A|1967-08-21|1971-08-04|Glaxo Lab Ltd|Improvements in or relating to cephalosporin compounds|
    GB1277415A|1968-06-14|1972-06-14|Glaxo Lab Ltd|Improvements in or relating to cephalosporin derivatives|
    US3641021A|1969-04-18|1972-02-08|Lilly Co Eli|3 7- cephalosporin compounds|
    US3776907A|1972-06-12|1973-12-04|Bristol Myers Co|7-)-3--carbonylthiomethyl-3-cephem-4-carboxylic acids|GB1565941A|1977-02-08|1980-04-23|Toyama Chemical Co Ltd|Process for producing 7-amino-3-substituted thiomethyl cephem carboxylic acids|
    US4314059A|1978-03-09|1982-02-02|Chisei Shibuya|Process for preparing cephalosporin compounds|
    DK225179A|1978-06-22|1979-12-23|Chugai Pharmaceutical Co Ltd|PROCEDURE FOR PREPARING CEPHALOSPORINE DERIVATIVES|
    JPS6027677B2|1978-07-06|1985-06-29|Toyama Chemical Co Ltd|
    JPS6310707B2|1978-09-22|1988-03-08|Sankyo Kk|
    JPS55139387A|1979-04-19|1980-10-31|Yamanouchi Pharmaceut Co Ltd|Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids|
    US4349672A|1979-11-29|1982-09-14|Hoffmann-La Roche Inc.|Cephalosporin derivatives|
    JPH0160477B2|1980-02-25|1989-12-22|Takeda Chemical Industries Ltd|
    DE3173499D1|1980-09-02|1986-02-27|Asahi Chemical Ind|Novel thioesters and process for the preparation of the same|
    US6166254A|1998-11-24|2000-12-26|Silicon Valley Chemlabs, Inc.|Method of manufacturing high purity amidoximes from hydroxylamine and nitriles|
    US20030135041A1|2002-01-04|2003-07-17|Orchid Chemicals & Pharmaceuticals Limited, India|Synthesis of ceftiofur intermediate|
    EP1394262A1|2002-08-30|2004-03-03|Bioferma Murcia, S.A.|An enzymatic process for preparing beta-lactams|
    CN102532166A|2010-12-27|2012-07-04|江苏九寿堂生物制品有限公司|Preparation method of refined ceftezole acid|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US77501877A| true| 1977-03-07|1977-03-07|
    [返回顶部]